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Preface 
This thesis describes the candidate’s work on the Blue Mountains Eye study 15-year follow-
up data. The Blue Mountains Eye study is a population-based cohort study of vision and 
common eye diseases in a suburban Australian population 49+ years residing in the Blue 
Mountains area, west of Sydney. The baseline examination examined 3654 participants 
between 1992 and 1994. Surviving baseline participants were invited to participate in the 5-, 
10- and 15-year follow-up examinations. Professor Paul Mitchell (candidate’s co- supervisor) 
is the Principal Investigator. Professors Jie Jin Wang (candidate’s primary supervisor), 
Robert Cumming, Wayne Smith and Stephen Leeder were co-investigators of this cohort 
study. 
This thesis examines the long-term incidence of visual impairment and blindness among 
older people and the associated impacts over the short-term and long-term. Aims of this 
thesis include the following: firstly to describe the changes in visual acuity among the Blue 
Mountains Eye study population over a 15-year period; Secondly, to investigate the 
associated impacts following the onset of visual impairment on the affected individuals and 
their family and community over time. 
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Abstract  
 
Purpose: To assess the long-term incidence of visual impairment (VI) in an older Australian 
population over a 15-year period, the association between diet quality and the incidence of 
VI, and associations between VI and the subsequent use of support services, subsequent 
events of falls, fractures, depressive symptoms, and cognitive decline over the short- (5 years) 
and long-terms (10+ years). 
Methods: The Blue Mountains Eye Study (BMES) is a population-based cohort study of 
vision and common eye diseases in a sample of Australians aged 49+ years, residing in the 
Blue Mountains area, west of Sydney. Surviving participants were invited to return 5-, 10- 
and 15-years after the baseline examination. 
VI was defined as best corrected visual acuity (VA) <6/12 (less than 39 letters read) with the 
exception of chapters 4 and 7 only, where presenting VA was used to defined different levels 
of VI. The incidence of bilateral VI was defined as the development of VI in the better eye at 
follow-up examinations when at least one eye was at risk of developing VI (VA≥6/12 at 
baseline). The incidence of unilateral VI was defined as the development of VI in the first eye 
at follow-up examinations when both eyes were at risk of developing VI at baseline. The 
incidence of any VI was defined as the development of bilateral or unilateral VI at the follow-
up examinations. 
Participants who had incident VI detected at the 5- and 10-year follow-up examinations were 
assessed for outcome events at the 10-year and 15-year follow-up examinations respectively, 
and a duration of 5 years or less between detecting VI and measures of outcome events was 
defined as “short-term”. Participants who had VI at baseline or incident VI detected at the 5-
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year follow-up examination were assessed for outcome events at the 10- and 15-year follow-
up examinations respectively, and a duration of 10+ years between VI diagnoses and outcome 
event measures was defined as “long-term”.  
 Face-to-face interviews and questionnaires were used to assess new use of community 
support services (formal support services), as well as the incidence of self-reported falls, 
fractures and depressive symptoms. We used a semi-quantitative food frequency 
questionnaire to calculate a total diet score (TDS) to assess diet quality. Participants in the 
highest TDS quartile were compared to people in the lowest TDS quartile. Mini Mental State 
Examination (MMSE) was performed at each of the three follow-up visits. A modified 
version of MMSE (after removing vision-related tasks, termed MMSE blind scores) was used 
and a reduction of ≥3 scores between the previous and subsequent visits was indicative of 
cognitive decline.  
All longitudinal associations were assessed after adjusting for baseline age, sex, education, 
presence of a walking disability (use of walking aids or a wheelchair), living arrangements, 
smoking status, alcohol consumption, self-rated health, chronic co-morbidities (self-reported 
histories of diabetes, hypertension, hyperlipidaemia, stroke, myocardial infarct, angina and 
arthritis) and having had a hospital admission in the 12 months prior to the baseline 
examination. Hazard ratios (HR) or odds ratios (OR) and 95% confidence intervals (95% CI) 
were estimated using discrete logistic regression or logistic regression models with time-
dependent variables when appropriate. 
Results: The 15-year cumulative incidence of unilateral and bilateral VI was 12.3% and 
5.2%, respectively. Approximately 40% of participants with mild VI (VA <6/12 but ≥6/24) 
improved to normal vision, while only approximately 10% of older participants with 
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moderate/severe VI (VA <6/24) improved to no visual impairment over the course of 15 
years. Participants aged 65+ years who consumed a high quality diet (in the highest TDS 
quartile), were found to have a reduced risk of developing any VI compared to participants 
who consumed a low quality diet (in the lowest TDS quartile) (adjusted HR 0.63, 95% CI 
0.38-0.98).   
Compared to participants with normal vision, participants with incident bilateral VI were 
more likely to subsequently need community support services (adjusted OR 3.32, CI 1.96-
5.59), to report experiencing ≥2 falls in the 12 months prior to the next follow-up visit 
(adjusted OR 1.46, 95% CI 1.04-2.04) and report subsequently the presence of depressive 
symptoms at the next follow-up visit (adjusted OR 3.06, 95% CI 1.72-5.44) over the short-
term since the detection of VI. Participants with incident bilateral VI, however, were not 
more likely to experience a fracture (adjusted OR 1.07, 95% CI 0.77-1.50) over the short-
term. Participants with any VI were also not more likely to have a decline (≥3 points) in 
MMSE scores (adjusted OR 0.74, 95% CI 0.26-2.17) over the short-term. 
 In contrast, compared to participants with normal vision, participants with incident bilateral 
VI were no longer more likely to subsequently use community support services (adjusted OR 
0.19, 95% CI 0.03-1.30), to report experiencing ≥2 falls (adjusted OR 0.36, 95% CI 0.04-
3.19) or report subsequently the presence of depressive symptoms (OR 1.29, 95% CI 0.84-
1.98) over the long-term. Similar to the findings over the short-term, there were no 
associations found between VI and subsequently self-reported fracture (OR 1.12, 95% CI 
0.22-5.74) or between VI and a decline in MMSE scores (OR 0.67, 95% CI 0.26-1.98) over 
the long-term. 
8 
 
Conclusions: We found similar incidence rates of VI as that were documented in other 
longitudinal studies. A healthy diet was associated with a reduced risk of developing VI in 
this older Australian sample.  
Within the first 5 years since VI was diagnosed, the demand for community support services, 
and adverse event rates such as falls and self-reported depressive symptoms, were higher 
among older participants with VI than those without. However, these associations diminished 
over the long-term (10+ years), suggesting possible adaptation of the impairment with aids 
and support, treatment and rehabilitation. The possibilities of reduced study power and 
healthy survival bias associated with older cohort samples may also partly explain the 
disappearance in these associations over the long-term. These findings highlight the 
importance of prevention, early detection and early treatment of VI to maintain the aging 
population in a healthy state for as long as possible. 
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Brief Summary 
Rationale of the Research Projects 
Though cross-sectional associations and short–term (≤ 5 years) longitudinal associations 
between visual impairment (VI) and increased risks of falls, fractures, depression and other 
adverse events in older persons have been reported previously1-10, there have been only few 
long-term follow-up (10+years) studies reporting the associations between VI and systemic 
health outcomes, and the findings have been inconsistent11-13. Limitations of previous studies 
include ambiguous information about definitions of VI (mostly self-reported) and duration of 
VI, relatively small sample sizes, and adjustment for limited numbers of confounding 
variables in statistical models. There has been no study conducted to assess the longitudinal 
associations of visual impairment with the subsequent use of community support services, the 
incidence of depression and cognitive decline. 
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Objectives of the Thesis Projects 
The objectives were to: 
- Report the long term incidence of visual impairment, blindness and the dynamic 
changes in visual impairment states among an older Australian population. 
- Describe the effect of diet quality on the long-term (10+ year) incidence of visual 
impairment. 
- Assess the impact of visual impairment on subsequent use of community support 
services over the short (5 years) and long-terms (10+ years). 
- Assess the associations of visual impairment with subsequent falls and fractures over 
the short and long-terms. 
- Assess the short and long-term associations of visual impairment with depressive 
symptoms at subsequent follow-up visits. 
- Assess the associations of sensory impairment (visual impairment and hearing loss) 
with the decline in Mini Mental State Examination Scores over short- and long-terms. 
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Key Findings 
Long Term Incidence of Visual Impairment in an Older Population 
The 15-year cumulative incidence of unilateral and bilateral VI (VA<6/12) was 12.3% and 
5.2%, respectively, while unilateral and bilateral blindness (VA<6/60), was 3.7% and 0.9%, 
respectively. There were no significant differences in the incidence rates of VI or blindness 
between men and women after adjusting for age. Deterioration of vision (a loss of ≥15 letters 
read) occurred in 6.9%, and an improvement in vision (a gain of ≥15 or more letters read) 
occurred in 1.6% of participants between baseline and the 15-year follow-up examination. 
Cataract was responsible for a majority (48.5%) of unilateral and bilateral incident VI, 
followed by age-related macular degeneration (26.9%). Age related macular degeneration 
was responsible for a majority of unilateral and bilateral incident blindness (56.9%), followed 
by cataract (20.7%).  Cataract surgery was the cause for visual improvements in the majority 
of persons. 
Cumulative incidence rates of VI and blindness increased significantly with age. The 
incidence rates observed in this older cohort, and were comparable to that of other 
longitudinal studies. 
 
Transition Rates of Visual Impairment States in Older Persons Over 5, 10 and 15 Years 
Multi-state Markov models were used to estimate the transitional probabilities between VI 
states while adjusting for age and sex. We found a low probability of worsening vision 
between baseline and the 5-, 10- and 15-year follow-up examinations (2-7%). There was a 2-
7% probability of improving vision from moderate/severe VI (VI<6/24) to mild VI (VA 
<6/12 but ≥6/24) between baseline and the 5-, 10- and 15-year follow-up examinations (7%, 
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3% and 2% respectively). There was approximately a 10% probability of improving vision 
from moderate/severe VI (VI<6/24) to no VI (≥6/12) between baseline and the 5-, 10- and 
15-year follow-up examinations (8%, 10% and 10% respectively). There was approximately 
a 40% probability of improving vision from mild VI to no VI between baseline and the 5-, 
10- and 15-year follow-up examinations (43%, 44% and 39% respectively). 
 
Adherence to Australian Dietary Guidelines and the 10-year Incidence of Visual 
Impairment 
A semi-quantitative food frequency questionnaire was used to calculate a total diet score 
(TDS) based on the Australian diet quality index. The risk of developing VI (VA <6/12 in 
one or both eyes) was lower among participants in the highest compared to the lowest TDS 
quartile (Hazard ratio (HR) 0.71, 95% confidence intervals (CI) 0.47-1.05) after adjusting for 
smoking, education and diabetes. This association was significant among participants aged 
65+years at baseline (HR 0.63, 95% CI 0.38-0.98) but not among those aged <65 years (HR 
0.95, 95% CI 0.46-1.97). The risk of VI reduced with each unit increase (e.g. improvement 
from 1 to 2) in the TDS (HR 0.94, 95% CI 0.88-1.00). A higher quality of diet and lifestyle, 
indicated by adherence to dietary guidelines, was associated with a decreased 10-year risk of 
VI in this older Australian cohort.  
 
Visual Impairment and the Use of Community Support Services among Older People 
Older participants who had incident VI were had a greater likelihood of subsequent use of 
community support services in 5 years, compared to those with normal vision during the 
entire follow-up period (OR 3.32, 95% CI 1.96-5.59 for incident bilateral VI and OR 1.77 
95% CI 1.21-2.60 for incident unilateral VI), after adjusting for age, sex, home ownership, 
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self-rated health, living arrangements, receiving a pension, had a walking disability, had a 
hospital admission in the last 12 months prior to baseline examination, and had 2+ co-
morbidities at baseline. Compared to people with no VI, participants with incident VI were 
not significantly more likely to rely on support from family or friends (informal supports) 
during the same follow-up period (OR 1.79, 95% CI 0.70-4.55 for incident bilateral VI and 
OR 1.60 95% CI 0.92-2.80 for incident unilateral VI).  
Compared to participants with normal vision, those with incident VI were no longer more 
likely to subsequently use community support services (OR 0.19, 95% CI 0.03-1.30 for 
bilateral VI and OR 0.93, 95% CI 0.49-1.74 for unilateral VI) in 10 or more years. Similarly, 
there were no associations between incident VI and subsequent use of informal supports (OR 
1.64, 95% CI 0.31-8.66 for bilateral and OR 1.11 95% CI 0.65-2.02 for unilateral VI) in 10 or 
more years. 
 
Visual Impairment and the Incidence of Falls and Fractures among Older People 
Older participants with incident VI were more likely to report having ≥2 falls in the 12 
months prior to the next 5-year follow-up visit, compared to participants with normal vision 
over the same follow-up period (OR 1.46, 95% CI 1.04-2.04 for bilateral and OR 1.22, 95% 
CI 0.98-1.51 for unilateral VI), after adjusting for age, sex, the presence of a walking 
disability and having 3 or more co-morbidities. Compared to participants with normal vision, 
those with incident unilateral VI had a higher incidence of fractures in 5 years (OR 1.27, 95% 
CI 1.04-1.55), however, no similar associations were observed among those with incident 
bilateral VI (OR 1.07, 95% CI 0.77-1.50).  
Compared to participants with normal vision, those with incident VI were not more likely to 
report ≥2 falls (OR 1.10, 95% CI 0.45-2.69 for bilateral VI and OR 1.26, 95% CI 0.79-2.01 
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for unilateral VI) or a fracture in 10 or more years (OR 1.27, 95% CI 0.53-3.06 for bilateral 
VI and OR 1.51, 95% CI 0.96-2.37 for unilateral VI). 
 
Visual Impairment and Subsequently Self-reported Depressive Symptoms among Older 
People 
Compared to participants with normal vision, participants with incident VI were more likely 
to report depressive symptoms in 5 years, after adjusting for age, sex, walking disability 
living arrangements, and hospital admission within 12 months of baseline (OR 4.60, 95% CI 
1.67-12.69 for bilateral and OR 4.06, 95% CI 2.06-7.99 for unilateral VI), but were not more 
likely to report depressive symptoms in 10 or more years (OR 0.63, 95% CI 0.17-2.34 for 
bilateral VI and OR 1.47, 95% CI 0.90-2.20 for unilateral VI). 
 
Sensory Impairment and Cognitive Function Decline among Older People 
Compared to participants with no sensory impairment, participants with the presence of any 
VI (VA<6/12 in the worse eye), hearing loss (>40 decibels in the worse ear), or both (dual 
sensory impairment) were not more likely to have a decline (reduction of ≥3 points) in mini-
mental state exam (MMSE) blind scores over 5 years, after excluding participants who had a 
history of stroke, and adjusting for age and sex (OR 0.74, 95% CI 0.26-2.17 for VI only, OR 
1.30, 95% CI 0.83-2.01 for hearing loss only, and OR 1.46, 95% CI 0.67-3.17 for dual 
sensory impairment). 
Compared to participants with no sensory impairment, participants with any VI, hearing 
impairment or both were not more likely to have a decline in MMSE blind scores over 10 or 
more years (OR 1.09, 95% CI 0.52-2.30, OR 1.09,  95% CI 0.65-1.82 and 1.15, 95% CI 0.28-
4.73 for those with VI only, hearing loss only and dual sensory impairment, respectively). 
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Older baseline age was found to be significantly associated with a decline in MMSE blind 
scores over 5 and 10+ years (OR 1.07, 95% CI 1.04-1.10 and OR 1.07, 95% CI 1.04-1.10 
respectively, for each year increase in age). 
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Chapter 1: The Incidence and Impact of Long-term 
Visual Impairment in Older People 
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Introduction 
Visual impairment (VI) affects up to 27% of people worldwide 14-24. A large majority of VI 
data in the literature were cross-sectional findings pertaining to the prevalence of VI in 
different populations19;20;25-36. 
The cross-sectional associations between VI and physical, mental and social functioning have 
been extensively studied, often with conflicting results. Several cross-sectional studies have 
also found associations between VI and the prevalence of falls and fractures 38;45-62. The 
prevalence of VI has consistently been found to be associated with the use of formal support 
services and help from family and friends37-40. A meta-analysis found a higher prevalence of 
depression among persons with VI (pooled Odds Ratio, OR 1.94 95% CI 1.68-2.25)41,  
however a study by Evans et al42 did not find any difference in the prevalence of depression 
between those with and those without VI after adjusting for age, sex and activities of daily 
living (ADL). Persons with VI have been reported to be more likely to have cognitive 
impairment than those without VI in some studies 43;44, however others have not found any 
associations after adjusting age, sex and history of cerebrovascular disease45;46.  
Limited longitudinal data regarding the incidence of VI and associated factors have been 
reported. This review aims to summarise the available data on the incidence of VI and 
blindness and the subsequent impacts of VI on both the affected individuals and their families 
and community. 
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Method of Literature Search 
We searched Medline and Pubmed for articles during August 2014 with the following search 
words: visual impairment, incidence, incident, longitudinal, eye study, impact, visual 
function, quality of life, QOL, cognitive function, cognition, depression, depressive 
symptoms, driving, falls, fractures, mortality, death, support, hospitalisation, 
institutionalisation, eye care. The search was limited to publications written in English, and 
covered the years 1980 to 2014. We also hand searched bibliographies of identified studies 
for additional references. 
1.1 Definitions of Visual Impairment and Blindness  
The term VI usually refers to a reduced visual acuity (VA), however visual field loss and a 
reduced contrast sensitivity have also been included in some reports18;63;64. For the purposes 
of the following summary, only VA measures of VI are considered. 
Various cut offs in the level of reduced VA have been used to define VI worldwide. The 
World Health Organisation (WHO) defines VI as best-corrected VA <6/1865. In the United 
States of America (USA)14 VI is usually defined as ≤6/12. In Australia VI is defined as VA 
<6/12, which is the minimum VA requirement to obtain and maintain an Australian drivers 
license66. 
Similar to VI, differing definitions of blindness are used worldwide. The WHO defines 
blindness as best-corrected VA <6/12065, whereas blindness is defined as ≤6/60 in the 
USA24;67 and <6/60 in Australia68;69. The incidence of VI and blindness refers to VI that is 
present in an eye at a follow-up examination, but it was not present at the previous 
examination. An eye is at risk of incident VI when the VA in that eye is better than the 
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defined VA cut off for VI in the corresponding report, e.g. according to the Australian 
definition of VI (VA<6/12), an eye is at risk of developing VI when VA≥6/12 at the previous 
examination67;68. 
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1.2 Incidence of Visual Impairment and Blindness in 
Older Persons 
Australian Studies 
The Blue Mountains Eye Study (BMES) baseline examinations were conducted between 
1992 and 1994 in the Blue Mountains area, west of Sydney70. Permanent residents aged 49+ 
years were eligible to participate. Out of 4433 eligible residents identified using a private, 
door-to-door census, 3654 persons (82.4% participation rate) took part in the study at 
baseline. Between 1997 and 1999, 75.1% (n=2335) of survivors returned for re-examination 
after 5-years. Foran et al68 reported that the 5-year incidence of bilateral VI (VA<6/12) was 
1.7% (n=37) and incident bilateral blindness (VA<6/60) was 0.1% (n=3)  in this population-
based sample of older Australians aged 49+ years who had normal vision at baseline. 
The Melbourne Visual Impairment Project (MVIP) was a population-based study of age-
related eye diseases conducted in 9 adjacent pairs of urban districts randomly selected from 
the Melbourne statistical division. Among 3941 eligible participants who resided at their 
current address for 6 months or longer, identified using a door-step approach and household 
census71, 3271 (83% participation rate) aged 40 years and over took part in the baseline 
examination between 1992 and 1994. Between 1997 and 1999, 2594 (85% of survivors) 
participants were subsequently re-examined. After 5 years, the reported incidence of bilateral 
VI (VA <6/12) was 4.2% (n=105), and bilateral blindness (VA<6/60) was found in 0.43% 
(n=11)72. 
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The Central Australian Ocular Health Study examined the 30 largest remote communities 
within the statistical local area of central Australia73. Of the 5173 persons aged 20 years and 
older within the target area, 1884 (36.4%) attended the remote clinics for examination and 
identified themselves as indigenous Australians between 2005 and 2008. Between 6 months 
and 3 years later (a median follow-up period of 2 years), 608 (32%) were subsequently re-
examined. Incident bilateral VI (VA<6/12) occurred in 11.4% (n=51) and blindness 
(VA<6/60) occurred in 0.84% (n=5) participants74. 
International Studies 
Studies with follow-up period 5 or less years 
The Los Angeles Latino Eye Study (LALES) was a population-based cohort study of 
participants of Latino background aged 40 years and over75. Of the 7789 eligible residents in 
6 census districts invited to participate in La Puente, California, USA, 6357 (82%) completed 
an in-home questionnaire and clinical examination between 2000 and 2003. Four years later, 
4658 participants were re-examined (76% of survivors). The 4-year incidence of bilateral VI 
(VA<6/12) was 1.2% (n=55) and blindness (VA≤6/60) was 0.3% (n=12)24. 
The Reykjavik Eye Study was a population-based cohort of Icelanders aged 50 years and 
over, during 199676. Participants were randomly selected from inhabitants of Reykjavik using 
the national population consensus. Of the 1379 persons randomly selected, 1045 persons 
(75.8%) were examined and 846 participants were subsequently re-examined (88.2% of 
survivors) during 2001. The 5-year incidence of bilateral VI (VA<6/12) was 3.49% (n=29) 
and bilateral blindness (VA≤6/60) was 0.95% (n=8)77. 
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The Beijing Eye Study was a population-based cohort of the greater Beijing area including 
both rural and urban areas during 2001. Of the 5324 eligible participants aged 40 years and 
over identified from local mayor registries, 4439 (83.4%) were examined in either school 
houses or community houses throughout the 7 communities78. After 5-years, 3251 
participants were re-examined (73.2% of survivors). The 5-year incidence of bilateral VI 
(VA<6/12) was 1.1% (n=35) and blindness (VA<6/60) was 0.1% (n=2)79. 
The Liwan Eye Study was a population-based study of participants aged 50 years and over 
during 2003 within urban southern China80. Of the 1864 eligible subjects who lived in the 
Liwan district for ≥6 months, 1405 (75.4%) were examined at baseline. During 2009 all 
participants were invited to take part in the follow-up examination, with 924 participants 
subsequently re-examined (75% of survivors). The 5-year incidence of bilateral VI 
(VA<6/12) was 9.85% (n=86) and blindness (VA≤6/60) was 1.42% (n=13)81. 
Studies with follow-up period greater than 5 years 
The Priverno Eye Study examined a cohort of 860 participants between the ages of 45 and 69 
years within the town of Priverno, Italy in 1987. This study sample was drawn from 
participants currently enrolled in another study of cardio-vascular risk factors18. After 7-
years, 619 participants (81.4%) were re-examined and the incidence of bilateral VI 
(VA<6/24) was found in 1.3% (n=8) of participants. The incidence of bilateral blindness 
(VA<6/120) was found in 0.2% (n=12) of participants82. 
The Barbados Eye Study (BES) was a population–based study between 1987 and 1992 to 
determine prevalence and risk factors for VI and major eye disease among predominately 
African American Barbadian-born citizens aged 40 to 84 years19. Of the 4631 participants 
examined at baseline, 3427 (85% of survivors) participants were re-examined between 1992 
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and 2003. The 9-year incidence of bilateral VI (VA≤6/12) was 6.4% (n=195) and bilateral 
blindness (VA≤6/60) 2.1% (n=69)83. 
The Ponza Eye Study examined residents of the island of Ponza, Italy, between 1986 and 
1988. Of the 3292 persons within the municipality, 1226 were eligible (aged 40 years and 
over) and invited to participate with 1028 (83.8%) participants completing the baseline 
examination18. After 12 years, 441 participants returned for re-examination (70.7% of 
survivors). Nucci et al84  reported the 12-year cumulative incidence of bilateral VI (VA<6/18) 
to be 3.9% (n=16), and bilateral blindness (VA<6/120) was 0.7% (n=3)84. 
The Copenhagen City Eye Study (CCES) was a population-based survey of vision and eye 
disease in persons aged 60 to 80 years as part of the wider Copenhagen City Heart Study. Of 
a randomly selected sample of 976 eligible participants between 1986 and 1988, 946 (96.9%) 
participants were examined at baseline26 and 359 participants (97.3% of survivors) were-re-
examined between 2000 and 2002. The 14-year cumulative incidence of bilateral VI 
(VA<6/12) was 16.7% (n=56) and of bilateral blindness (VA<6/60) was 5.1% (n=18)85. 
Beaver Dam Eye Study (BDES) is the only study reporting 5-, 10-, 15- and 20-year 
longitudinal data on vision changes among older persons. The baseline study was conducted 
between 1987 and 1988. Of the 5924 eligible residents of the city of Beaver Dam aged 43 to 
84 years, 4926 (83.2%) completed the baseline examination86. Participants were invited to 
attend follow-up examinations 5-, 10-, 15- and 20-years after the baseline examination. The 
5-, 10- and 15-year cumulative incidence of VI was 2.9% 5.9% and 8.0 % respectively. The 
corresponding cumulative incidence of blindness was 0.3%, 0.8% and 0.8% 
respectively14;15;67. The 20-year follow-up examinations were conducted between 2008 and 
2010, with 1758 participants (89.4% of survivors) being re-examined. The estimated 20-year 
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cumulative incidence of bilateral VI (VA<6/12) varied from 0.6% among persons aged 50 
years of age to 30.3% in persons aged 75 years. The corresponding cumulative incidence of 
bilateral blindness (VA≤6/60) varied from 0.3% to 2.7%87. 
The incidence of VI and blindness in the reported studies have been summarised in Table 
1.1. 
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Table 1.1: Summary of major population-based studies of the incidence of visual impairment among older people 
Years of 
baseline 
examinations 
Name/location Population 
size at 
baseline 
Years of 
follow-up    
Age at 
baseline 
(years) 
Incidence of visual impairment (%) 
 definition by visual acuity level  
Incidence of blindness (%) 
definition by visual acuity level 
     <6/12 ≤6/12 <6/18 <6/24 <6/60 ≤6/60 <6/120 
Australian 
2005-2008 CAOHS* 1884 2 20+ 11.4    0.84   
1992-1994 BMES† 3654 5 49-97 1.7 1.9   0.1 0.1  
1992-1994 MVIP‡ 3271 5 40-84 4.2    0.43   
International 
2000-2003 LALES§ 4439 4 50+ 1.2  0.8   0.3  
1996 Reykjavik 1045 5 50+ 3.49  1.07   0.95 0.35 
2001 Beijing 6357 5 40+ 1.1    0.1   
2003 Liwan 1045 5 60+ 9.85  5.38   1.42 0.33 
1987 Priverno  860 7 45-69    1.3   0.3 
1987-1992 Barbados 4631 9 40-84  6.4 4.5   2.1 1.0 
1986-1988 Ponza 1028 12 40+   3.9    0.7 
1986-1988 Copenhagen 946 14 60-80 16.7    5.1   
1987-1988 BDES** 4926 20 43-84 0.6-30.3     0.3-2.7 0.2 
* Central Australian Ocular Health Study 
† Blue Mountains Eye Study 
‡ Melbourne Visual Impairment Study 
§ Los Angeles Latino Eye Study 
** Beaver Dam Eye Study 
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1.3 Impact of Visual Impairment on the Affected Older 
Individuals 
Visual function 
Visual function encompasses many aspects of vision including; VA, visual field and contrast 
sensitivity 88;89. VA is the most widely used measure of visual function; however, recently, 
questionnaires assessing vision-related quality of life have also been used in research and 
clinical practice to assess changes in patient perceptions of visual function associated with 
progression and treatment of ocular diseases49;90-92.  
A reduction in VA associated with progression of cataract and AMD has previously been 
found to be correlated with a reduced visual function measured with visual function 
questionnaires93-95. Many studies have found short-term improvements in visual function 
following cataract surgery 96;97. Some studies have assessed the long-term improvements in 
visual function following cataract surgery and found that short-term gains in visual function 
gradually decrease over a period of up to 10 years. The sample sizes of these studies were 
relatively small (n<550)98;99.  
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Physical function 
Mobility, Falls and Fractures 
Mobility is an important aspect of daily function, and requires the co-ordination of a number 
of different physiological processes, including vision. The BDES found that persons with 
bilateral VI were more likely to use walking aids after 5 years compared to persons without 
VI, although the risk estimate was not statistically significant after adjusting for age, gender, 
diabetes and self-rated health (OR 2.4, 95% CI 0.9-6.7)87. The Salisbury Eye Evaluation 
Study found a correlation between a reduction in VA and an increase in difficulties of ADL 
over 8 years100.  
Falls are common among older people and can lead to permanent physical and psychological 
disability101. The multi-factorial nature of falls among older people has been well 
documented, and vision is an inconsistent risk factor102;103 . The BMES reported no apparent 
associations between baseline VI status (VA<6/12) and risk of hip fracture after 5 years (age 
and sex adjusted Hazard Ratio, HR 1.1 95% CI 0.3-4.4)6. The Auckland Hip Fracture Study 
(AHFS)7 showed an increased risk of hip fractures within 2.5 years of VI detection (age and 
sex adjusted OR 1.5 95% CI 1.1-2.0) among persons with VI (VA<6/18) at baseline. 
However, the exact duration of VI cases at baseline was unclear in both the BMES and 
AHFS. The Framingham Eye Study12 examined 2675 participants at baseline between 1973 
and 1975, and found an increased risk of subsequent fractures over a 10-year period among 
persons with moderate VI in at least 1 eye (VA 6/9-6/24) detected at baseline after adjusting 
for age, sex, weight and alcohol use (Risk Ratio, RR 1.5, 95% CI 0.95-2.5), although this was 
marginally non-significant. A study by Javitt et al1 found that progressive visual loss was 
associated with an increased risk of non-specific injury over a 4 year follow-up period. The 
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BDES found that persons with bilateral VI were more like to experience two or more falls 
after adjusting for age, sex, self-rated health, diabetes and arthritis (OR 1.6, 95% CI 0.8-3.1) 
and fractures (OR 2.0, 95% CI 1.1-3.6, adjusted for age, sex and diabetes) in the subsequent 5 
years following detection of VI3. 
Although there have been several studies assessing the longitudinal associations between VI 
and falls and fractures, the exact duration of VI have been unclear in some studies 6;7;12. The 
longitudinal associations found between VI with falls and fractures have been consistent over 
the short-term1;3;7, however as time progresses, these associations appear to be weaken or to 
disappear.12  
Driving 
There are various criteria for the required VA level, with or without visual field 
measurement, to obtain a driver’s licence around the world. The presence of VI deprives the 
sufferer of the privilege of a licence, and the loss of independence due to cessation of driving 
could be associated with psychological stress of the affected individuals104;105. However, 
persons who wilfully stop driving due to visual problems may have come to terms with their 
impairment over time, and cope better compared to those who have their license taken away 
for the same reason106.  
Some studies have reported that even though persons with VI do worse on driving simulators, 
this did not translate into higher risk of road accidents107. Visually impaired persons were 
found to be cautious of their visual limitations, and less likely to take risks whilst driving 
leading to actions which may reduce accidents such as driving slowly and locally only, and 
limiting driving at night or under low light conditions such as rainy days108-110.  
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However, the BDES did not find that persons with bilateral VI were more likely to stop 
driving at night in the following 5 years since VI was detected (OR 0.8, 95% CI 0.2-3.4)111. 
Conversely, the Salisbury Eye Evaluation Driving Study (SEEDS) investigators examined 
1452 licensed drivers aged between 67 and 87 years of age, and found that  a decrease in 
contrast sensitivity was associated with cessation of driving over the following 12 months 
after adjusting for age and sex (OR 1.2, 95% CI 1.0-1.2)112. 
Mental and cognitive function 
Depression 
Both VI and depression have increasingly been recognised as major issues affecting the 
overall well-being of older people113-117. Depression has been reported to be associated with 
detrimental effects on physical, mental and social functioning16;118;119. Depressive symptoms 
have been found to be more prevalent among persons with specific vision-impairing eye 
diseases such as AMD and diabetic retinopathy compared to persons without these 
conditions51;120.  
There have been a few longitudinal studies assessing the associations between VI and 
depression, and conflicting results have been reported2;5;8. A retrospective study by Tournier 
et al5 found that VI was  associated with a greater incidence of depression in an older 
Canadian population (65+ years) over a 3 year period after adjusting for age, sex, chronic 
diseases and a history of depression  (HR 1.35, 95% CI 1.09-1.69 for moderate VI). Harris et 
al2 found that persons with poor vision at baseline were associated with incident depression 
detected at the 2-year follow-up visit after adjusting for age, sex, location and baseline 
depression (OR 2.9, 95% CI 1.3-6.3).  However, a study by Prince et al8 followed a cohort of 
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889 residents of London aged 65+ years over a 1 year period, and found that self-reported 
eyesight problems were not associated with development of depression in 1 year (adjusted 
OR 0.8, 95% CI 0.3-2.1). Similarly, a study by Forsell et al4 did not find any associations 
between VI and the onset of depression after 3 years in a Swedish population aged 75+ years. 
The duration and definitions of VI or poor vision have been unclearly reported from these 
above studies, making comparisons across studies difficult. 
Cognitive function 
Longitudinal studies have reported an association between VI and cognitive function decline 
in older persons9;11;13. Lin et al examined 6112 women aged 69 years and older in the Study 
of Osteoporotic Fractures9 and found a greater risk of subsequent cognitive decline among 
persons with VI after an average of 4.4 years compared to persons without VI. After 
adjusting for age, education, smoking, vertebral fracture, body mass index (BMI), grip 
strength, social network and baseline cognitive status, persons with bilateral VI (VA<6/12) at 
baseline were more likely to experience cognitive decline (OR 1.78 95% CI 1.21-2.61)9. The 
Maastricht Aging Study11 investigators examined 418 Dutch adults aged 55 years and older, 
and found that a deterioration in VA over a 6-year period was associated with a decline in 
cognitive function at the 6 year follow-up examination. Reyes-Ortiz et al13 examined 2140 
Mexican Americans aged 65 years and older at the baseline examination between 1998 and 
1999, participants were subsequently re-examined 2-, 5- and  7-years later. Persons with near 
VI (<7-point type size) at baseline had an average decline of  0.13 more MMSE blind scores 
per year than the average decline in persons with normal near vision over the 7 year period 
(p=0.045). They found, however, no difference in the change in MMSE blind scores per year 
between persons with distance VI and those with normal distant vision at baseline (p=0.14)13. 
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Although a decline in VA was associated with a subsequent decline in cognitive function 
over time among older persons in these studies, age and other factors may have contributed to 
the decline of both visual and cognitive functions. In the above mentioned studies, the 
duration of VI was not clearly defined. 
Mortality 
Several population-based studies have found that VI was associated with an increased risk of 
death among older people, compared to their aged peers without VI10;121-126. The BMES 
found an increased 5-year risk of death among people with VI (VA<6/12) at baseline, 
adjusted for age, sex, home ownership, self-rated health, BMI, history of co-morbidities, 
smoking status and alcohol consumption (RR 1.7, 95% CI 1.2-2.3)121. The BDES123 found an 
increased risk of death after 14 years among persons with VI (VA≤6/12) at baseline, after 
adjusting for age, sex, proteinuria, history of cancer, BMI, education, smoking status and 
history of other co-morbidities (HR 1.16, 95% CI 1.03-1.32). The MVIP found an increased 
5-year risk of death among persons with VI (VA<6/12) at baseline, after adjusting for age, 
sex, smoking status, hypertension, arthritis (OR 2.34 95% CI 1.03-5.32) 122. Thiagarajam et al 
found an increased risk of death among elderly persons (75+ year) with VI (VA<6/18) in the 
United Kingdom after adjusting for age, sex, BMI, ADLs, and co-morbidities (rate ratio 1.17, 
95% CI 1.07-1.27)124. The Jerusalem Longitudinal Study10 examined 261 persons aged 
70+years and found an increased risk of death after 7 years among persons with VI 
(VA≤6/12), after adjusting for  sex, self-rated health, ADLs, smoking status, financial 
difficulties and co-morbidities (OR 2.84, 95% CI 1.48-5.46). 
As to specific eye diseases and mortality, the Beijing Eye study found that cataract, 
retinopathy and glaucoma were associated with an increased risk of death compared to 
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persons with no major eye diseases, after adjusting for age, sex, rural or urban region, 
education and smoking status (p<0.01 for all)125. The CCES126 followed 946 people for 14 
years and reported women but not men with any AMD (early or late) had an increased risk of 
death compared to persons without AMD, after adjusting for age, sex, smoking status, 
hypertension, diabetes, and cardiovascular disease (HR 1.59, 95% CI 1.23-2.07). The 
association between VI and mortality among older persons could have been due to the effect 
of other underlying co-morbidities, and therefore the VI-mortality association is likely to be 
indirect.  
Other studies have assessed the underlying factors responsible for the association between VI 
and mortality, or factors that may coexist with VI and are known to be associated with 
mortality, including diabetes, cardiovascular disease, injuries and depression. Walking 
disability, indicative of frailty, was consistently found to be a possible factor partially 
explaining the increased risk of death among older persons with VI127;128. The SEE study129 
persons with VI at baseline were indirectly at an increased risk of death by way of decreasing 
instrumental ADL over time  (HR 1.16, 95% CI 1.04-1.28) using structural equation 
modelling adjusted for age, sex, race, smoking status, alcohol consumption, BMI, depression 
and co-morbidities. In addition, older age and other co-existing age-related co-morbidities are 
highly likely the reasons explaining the association between VI and poor survival. Whilst 
most studies reporting this association had controlled for co-factors associated with mortality, 
the co-factors that were adjusted for were inconsistent across studies and unlikely to be 
inclusive of all confounding factors.  
Although it would not be possible to adjust for all residual confounding effects, evidence 
supporting a reverse association, i.e. the association between correction of VI and improved 
survival, would have important implications to eye health care provision to older persons 
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with VI. The SEE study130 found that persons who gained 2+ lines over 2 years were less 
likely to die in the next 10 years after adjusting for age, sex, race, smoking history, BMI, 
diabetes and other co morbidities (HR 0.47, 95% CI 0.23-0.95). Blundell et al131 found that 
correcting cataract-related VI via cataract surgery was associated with a significantly 
decreased risk of mortality after adjusting for age and sex (standardised mortality rates 0.88, 
95% CI 0.79-0.99)131. Compared to persons with persistent VI due to cataract who did not 
have cataract surgery, the BMES found a 45% reduction in the 15-year risk of death among 
354 participants who had had cataract surgery to correct VI, after adjusting for age, sex, 
smoking status, BMI, home ownership, qualifications, poor self-rated health, poor mobility 
and co-morbidities (HR 0.55, 95% CI 0.35-0.86)132. In addition, the same group of authors, 
Fong et al133, also found that cataract surgical patients who no longer had VI one month post 
cataract surgery were 30% less likely to die in the next 5 years, compared to cataract surgical 
patients who had persistent moderate-sever VI post-operatively. This protective association 
was after adjusting for age, sex, smoking status, BMI and co-morbidities (HR 0.71, 95% CI 
0.51-0.99)133.  Evidence supporting a reverse association between correction of VI and 
improved survival among older persons suggests the benefit of eye health care to older people 
with VI is beyond the eye, vision and visual functions.    
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1.4 Impact of Visual Impairment on the Community 
Support use 
Though some studies have reported the associations between VI and loss of independence, 
findings were largely from cross-sectional studies38;57;58. There has been few longitudinal data 
to support the sustained or incident use of support services subsequent to development of VI. 
The Jerusalem Longitudinal Study found that baseline VI (VA≤6/12) among participants 
aged 70+ year was associated with a subsequent greater dependence in ADLs over an 8-year 
period10.  
Hospitalisation and institutionalisation 
A study by Evans et al134 conducted among 14394 persons aged 75+ years, found a slightly 
increased likelihood of hospital admission in persons with VI (<6/18) over a 2 year period, 
after adjusting for age, sex, housing tenure, financial difficulties, smoking, diabetes, major 
illness and MMSE score (RR 1.19, 95% CI 1.06-1.34). Persons with VI were also found to 
have longer durations of hospital stay compared to persons without VI, although this could be 
due to the increased co-morbidities associated with VI134;135. The BMES found that baseline 
bilateral VI (≤6/12) was associated with an increased risk of nursing home placement over 6 
years following baseline examinations, after adjusting for age, home ownership, self-rated 
health walking disability and smoking status (RR 1.8, 95% CI 1.1-2.9)37. The BDES found 
that persons with binocular incident VI (≤6/12) were more likely to be newly admitted to a 
nursing home within the next 5 years, after adjusting for age, sex, self-rated health and 
arthritis (OR 4.2, 95% CI 2.3-7.6)111. 
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Eye care and economic burden  
A study by Sloan et al found that persons having regular eye exams were less likely to 
experience visual decline136. Screening programs have been implemented worldwide with the 
focus on early detection and management of VI 137;138 A retrospective study by Maclennan et 
al found that among persons diagnosed with an eye problem, eye care use was found in 
33.2% of the cohort within 1 year and 45% within 2 years139. Many factors could affect the 
use of eye care services by those who need these services. In general, the main reasons for 
not using eye care services were economic and cultural factors140-146.  
A systematic review on the economic burden of VI and blindness of 22 studies by Koberlein 
et al147 found that there is a considerable impact of VI and blindness on direct and indirect 
costs to the individual and the community. Costs to the individual include a loss of 
independence and productivity. VI also adversely impacts on the ability of individuals to 
participate in social and community activities55;148;149. There is also an increased use of 
formal and informal support services37-40.  
Overall, Wittenborn et al145 found that in the US, indirect cost of VI were $13 billion and the 
direct cost of VI were $14.5 billion. In Australia, a study by Taylor et al113 estimated direct 
and indirect cost of VI in 2004 to be $1.8 billion and $3.2 billion AUD respectively. 
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1.5 Summary 
In summary, many longitudinal population-based studies have reported the incidence of 
visual impairment and blindness among older people. Many studies have also reported the 
impact of visual impairment on the affected individual and their community. However, 
findings have mainly been short-term associations5;6;10;11;37;87;111;121;122;125, and a limited 
number of studies have reported the associations over 10 or more years.  
While the short–term associations between VI and the increased risk of falls, fractures and 
depression has been consistent, the long-term associations have not been consistent2;3;5;8;87;100. 
This could have resulted from limitations of previous studies, including poorly defined VI 
and unclear duration of VI, relatively small sample sizes, and different confounding variables 
included in statistical models. In addition, little data exist for the long-term associations 
between VI and the subsequent use of support services, and between VI and incidence of 
depression or cognitive decline. Longitudinal studies with clearly defined VI and information 
of temporal relation may help better understanding the impacts of VI, and better planning of 
eye health and aged care for the aging population.  
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 Section II 
Study Sample and Methods 
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Section II 
Study Sample and Methods 
 
Chapter 2: Characteristics and Follow-up of the 
Blue Mountains Eye Study population, Data 
Collection Methods, Definitions, Statistical Methods 
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2.1 Characteristics and Follow-up of the Blue 
Mountains Eye Study population 
The Blue Mountains Eye study (BMES) is a population-based cohort study of vision and 
common eye diseases in a suburban Australian population 49+ years residing in the Blue 
Mountains area, west of Sydney. Detailed methods of the baseline survey were reported 
previously70. In summary, at baseline we recruited and examined 3654 participants between 
1992 and 1994. Surviving baseline participants were invited to participate in the 5-, 10- and 
15-year follow-up examinations. Of these, 2334 returned after 5 years (75.8% of survivors), 
1952 after 10 years (76.7% of survivors) and 1149 after 15 years (56.1% of survivors). Over 
the period between the 10- and 15-year visits, 364 had moved, 81 were admitted to a nursing 
home and were too frail to participate, 454 refused re-examination, and 496 had died (Figure 
2.1). 
All baseline and follow-up examinations of the BMES were approved by the Human 
Research Ethics Committees of the University of Sydney and the Western Sydney Area 
Health Service, and were conducted adhering to the tenets of the Declaration of Helsinki. 
Signed informed consent was obtained from all participants at each examination visit. 
  
56 
 
Figure 2.1: Participation Flow Chart of the Blue Mountains Eye study (BMES) cohort: 3654 
participants were examined at baseline (BMES I), 2334 (75.8% of 3079 surviving 
participants) returned after 5 years (BMES II), 1952 (76.7% of 2544 surviving participants) 
after 10 years (BMES III) and 1149 (56.1% of 2048 surviving participants) after 15 years 
(BMES IV). 
 
 
 
 
 
 
 
 
  
3654 Examined BMES I 1992-1994 
575 Deceased 
3079 Eligible persons 
5-year follow-up 
10-year follow-up 
15-year follow-up 
BMES II 1997-1999 
BMES IV 2007-2010 
1952 Examined 
496 Deceased 
454 Refused 2048 Eligible persons 
1149 Examined 
592 Refused/Moved 
BMES III 2002-2004 
745 Refused/Moved 
2544 Eligible persons 
535 Deceased 
2334 Examined 
81 Too frail 
364 Moved 
4433 Eligible persons 
779 Refused/Died 
before examination 
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A comparison of some differences in demographic and socio-economic characteristics 
between participants of the baseline BMES population and the Australian population are 
presented in Table 2.1. The baseline BMES population was slightly older compared to the 
Australian population, and a higher proportion of BMES participants reported owning their 
own home and were born outside of Australia. 
 
Table 2.1: Comparison of demographic and socio-economic characteristics between the 
baseline Blue Mountains Eye study (BMES) population (1992-1993) and the Australian 
population (1991 census data) aged 50 years or older38. 
 BMES Australian 
 Women Men Women Men 
Age (years) % % % % 
49 0.6 0.7 3.8 4.5 
50-59 27.2 27.4 32.8 38.0 
60-69 26.9 25.5 21.8 18.6 
70-79 26.9 25.5 21.8 18.6 
80* 10.6 9.2 11.0 6.2 
Marital status     
    Never married 8.0 7.0 5.3 7.3 
    Now married 51.8 77.1 58.4 77.0 
    Separated/divorced 13.6 8.3 8.0 8.5 
    Widowed 26.5 7.6 28.3 7.2 
Country of birth     
    Outside Australia 38.0 42.0 30.4 35.1 
Home ownership 87.3 90.1 79.3 79.9 
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Table 2.2 presents selected characteristics of participants of the Blue Mountains Eye study 
baseline population. Approximately 63% of participants were married, 89% owned a home 
and 28% lived alone. 
 
Table 2.2: Selected characteristics of participant of the Blue Mountains Eye study baseline 
population (n=3654)70;150. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Age-related Macular Degeneration 
Characteristic n % 
Female 2072 56.7 
Age   
    <60 1019 27.9 
    60-69 1309 35.8 
    70-79 960 26.3 
    80-89 330 9.0 
    90+ 36 1.0 
Married 2289 62.8 
Lives alone 991 27.5 
Owns home 3153 88.6 
Current smoker 491 13.4 
History of   
    Cataract 603 16.5 
    Glaucoma 219 6.0 
    AMD* 88 2.4 
    Hypertension 1480 40.5 
    Diabetes 218 6.0 
    Stroke 194 5.3 
    Heart disease 587 16.2 
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2.2 Data Collection Methods 
Examination procedures 
The details of the examination procedures for the Blue Mountains Eye Study baseline 
examination have been described previously70, the 5- and 10-year follow-up examinations 
used similar procedures (Appendix 1). Details of the 15-year follow-up examination 
procedures used in this study are briefly described below. 
Study Questionnaire 
A comprehensive interview-administered questionnaire was conducted detailing socio-
demographic characteristics, driving, dependency, mobility, self-rated health, family history 
of eye disease. Past surgical and medical histories of angina, acute myocardial infarct, stroke, 
arthritis, hypertension, diabetes, the presence of a walking disability (the use of a cane, 
crutch, walking frame or wheelchair) and any hospital admissions (at least overnight) in the 
12 months prior to each visit, smoking, alcohol intake, past and current medication use 
(Appendix 2). 
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Use of Community and Informal Support Services 
Participants were asked the following questions to determine the use of community and 
informal support services; 
• Do you get regular help from Meals on Wheels?  
• Do you get regular home visits from a community nurse? 
• Do you get regular visits from Home Care?  
• Who usually cleans your house? 
• Who usually does your shopping? 
• Are you able to go out alone? 
Assessment of Falls and Fractures 
Participants were asked the following question to determine the occurrence of falls over a 12-
month period prior to the study examination; “During the past 12 months, have there been 
any falls where you have landed on the ground or floor?” If the response was yes, additional 
questions were asked including how many falls they had suffered.  
Participants were asked the following question to determine the incidence of fractures over a 
5-year period between the visit when visual impairment was detected and the subsequent visit 
after visual impairment was detected; “Have you broken or fractured a bone since the last 
examination?” 
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Assessment of Depressive Symptom  
Depressive symptoms were assessed using the Mental Health Index (MHI) component of the 
Short-Form-36 (SF-36). The SF-36 self-rated health questionnaire addresses a wide range of 
health issues consisting of eight separate domains including; Physical Function, Role 
Function Physical, Role Function Emotional, Social Function, General Health, Mental 
Health, Vitality and Pain. The Mental Health Index (MHI) component of the SF-36 has 
previously been validated as a screening instrument to detect depressive symptoms among 
elderly participants151;152. The MHI consists of five questions relating to the prior 4 weeks 
“Have you been very nervous? Have you felt so down in the dumps that nothing could cheer 
you up? Have you felt calm and peaceful? Have you felt down? Have you been happy?”. The 
responses to these questions were limited to; “All of the time, most of the time, a good bit of 
the time, a little of the time, none of the time” and were allocated a score between 1 and 6. 
An overall score was calculated by adding the scores of the five responses, subtracting 5 and 
multiplying by 4. This results in a score between 0 and 100, with 100 indicating the best 
mental health. A score of <59 is indicative of having depressive symptoms152. Self-reported 
use of anti-depressant medication was considered as severe manifestation of depressive 
symptoms requiring treatment. 
Assessment of Cognitive Function  
Cognitive function was assessed using a modified version of min-mental state exam 
(MMSE), termed MMSE blind, excluding  vision-related items with remaining items 
conserving the purpose of assessing memory, calculation and orientation60;153;154. Tasks of 
MMSE blind are added up to a maximum score of 22 (indicating the best level of cognitive 
function). 
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Dietary Assessment 
Diet was assessed with a semi-quantitative food frequency questionnaire which included 145 
items adapted for the Australian diet from a Willett food frequency questionnaire 155. 
Participants used a frequency scale ranging from never to four times a day to indicate typical 
consumption of particular food items throughout the past year. Participants were excluded if 
their food frequency questionnaires had more than 12 food frequency questionnaire items 
missing; had energy intakes <2500kJ or >18000kJ. Finally, nutrient data were screened for 
extreme values, inspecting values in the upper and lower 2% of the distribution to locate and 
correct any data entry errors and to check for plausibility, by an accredited practising 
dietician (VF). Validity of the food frequency questionnaire was assessed in a subsample 
(n=78) at baseline comparing nutrient intakes from the food frequency questionnaire to the 
weighed food records over twelve days 155;156, energy adjusted Spearman correlations above 
0.5 were found for most nutrients. Australian Tables of Food Composition were used to 
estimate dietary nutrient intakes, using the electronic database NUTTAB90 157 for the food 
frequency questionnaires collected at baseline and a purpose built software analysis system to 
generate average daily nutrient intake.  
Visual Acuity Assessment 
VA was measured prior to pupil dilation using a retro-illuminated logarithm of minimum 
angle of resolution (LogMAR) chart (Vectorvision CSV-100TM, Vectorvision, Inc, Daytona, 
OH). Distance VA was measured at 244 cm for each eye with current spectacles if worn, 
followed by pinhole acuity. Either a previous spectacle prescription or an auto-refraction 
(Humphrey automatic refractor, model 597, Humphrey-Zeiss, Germany) provided the 
baseline for a subjective refraction.  
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Subjective refraction was performed using the Early Treatment Diabetic Retinopathy Study 
protocol158. VA was recorded as the number of letters read correctly in each eye (from 0-70). 
Table 2.3 shows the equivalent scores. If no letters could be read from the chart at 244cm, 
VA was further assessed at 61cm, and recorded as count fingers, hand movements, light 
perception, or no light perception.  
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Table 2.3: Equivalent letter scores for reading logMAR chart at 244 cm and 61 cm 
Letter Score 
2.44m 
Snellen VA 
244 cm 
LogMAR VA 
244 cm 
Snellen VA 
61 cm 
LogMAR VA 
61 cm 
5 6/60 1.0 6/150 1.4 
10 6/48 0.9 6/120 1.3 
15 6/38 0.8 6/95 1.2 
20 6/30 0.7 6/75 1.1 
25 6/24 0.6 6/60 1.0 
30 6/19 0.5 6/48 0.9 
35 6/15 0.4 6/38 0.8 
40 6/12 0.3 6/30 0.7 
45 6/9.5 0.2 6/24 0.6 
50 6/7.5 0.1 6/19 0.5 
55 6/6 0.0 6/15 0.4 
60 6/4.8 -0.1 6/12 0.3 
65 6/3.8 -0.2 6/9.5 0.2 
70 6/3 -0.3 6/7.5 0.1 
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Hearing Assessment 
Hearing was assessed at the 5-, 10- and 15-year follow-up examinations by means of pure-
tone audiometry (PTA), performed by an audiologist in sound-proof booths using THD-39 
(total dynamic distortion-39) earphones and Madsen OB822 audiometers (Madsen 
Electronics, Denmark).  
Measurement of other variables 
Peripheral visual fields were assessed via automated perimetry in both eyes using Humphrey 
24-2 Sita Standard tests (Humphrey-Zeiss, Model 530, Germany). After pupil dilation with 
tropicamide 1% and phenylephrine 10%, eye examinations were performed including a slit 
lamp (Haag Streit) and retro-illumination (Neitz) camera to assess the lens. Retinal 
photographs were taken using a Canon fundus camera with digital back (CF-60DSi, EOS 1Ds 
Mk III, Japan). 
Diagnosis of the causes of Visual Impairment 
Cataract was diagnosed during the dilated slit lamp examinations and also recorded during 
lens photographic grading. AMD was diagnosed at the time the dilated fundus examination 
was conducted and confirmed by retinal photographic grading. Glaucoma was diagnosed 
when glaucomatous field loss was detected, based on repeated visual field tests where the 
visual field defect corresponded to optic disc changes, consistent with typical glaucomatous 
cupping 159. 
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2.3 Definitions of Visual Impairment  
A number of different definitions of VI have been used worldwide, which have been 
described earlier. The definition of VI may vary between chapters to allow for comparison 
between Australian and international reports. Visual acuity was based on the number of 
letters read correctly on a LogMar chart, and usually refers to best-corrected VA (defined as 
VA after subjective refraction) throughout this thesis unless specified. We used best-
corrected VA for a majority of the analysis to assess the associations between true VI and the 
outcome variables. Presenting or habitual VA (defined as VA measured before subjective 
refraction) was used in Chapters 4 and 7 only (Table 2.4). As falls usually occur when the 
subject is wearing their current spectacles or no spectacles at all, we used presenting VA in 
the primary analysis of VI and falls and fractures.  A supplementary analysis using best-
corrected VA was also performed in this chapter. We used presenting VA in Chapter 4 to 
increase the number of cases for the analysis; we also assessed VI according to best-corrected 
VA in Chapter 4 but the number of cases was too small. VI was defined as VA <6/12 (39 
letters or less letters read), and blindness as VA <6/60 (4 letters or less read) unless specified. 
The definition for VI is in keeping with the definitions used in previous BMES reports, and it 
is the minimum VA requirement to obtain and maintain an Australian Driver’s license. 
An eye was considered to be at risk of developing VI if VA was 6/12 or better and at risk of 
developing blindness if VA was 6/60 or better at baseline. Incident unilateral VI was defined 
as development of VI in only one eye (the worse eye) at follow-up visits where both eyes 
were at risk of VI at baseline. Similarly, incident bilateral VI was defined as development of 
VI in both eyes when at least one eye was at risk of developing VI at baseline, and was 
defined based on VA in the better eye at follow-up. In addition, incident any VI was defined 
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as having at least one eye at risk of developing VI at baseline where the at-risk eye was found 
to have VI at the follow-up examination.  
Incidence of any blindness was defined as having at least one eye at risk of developing 
blindness at baseline and that the at-risk eye was found to develop blindness at the follow-up 
examination. 
Table 2.4: Definitions of visual impairment in each chapter by eye and visual acuity 
measurement. 
 
 
Chapter 
 
Topic 
 
Eye 
Best-
corrected or 
presenting 
Visual Acuity 
3 Cumulative Incidence of VI Better and Worse or either BCVA 
4 Dynamic Changes in Vision Better Presenting 
5 Total Diet Score and incidence of VI Better and Worse BCVA 
6 Support Use Better and Worse or either BCVA 
7 Falls and Fractures Better and Worse Presenting 
8 Depressive symptoms Better and Worse or either BCVA 
9 Cognitive Decline Better or Worse BCVA 
 
VI - visual impairment 
BCVA – best-corrected visual acuity 
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2.4 Statistical Analysis 
SAS (Version 9, SAS Institute Inc, Cary, NC) was used for all analyses, with the exception of 
Chapter 4.  Age was defined as age at baseline for all analysis.  
Cumulative 15-year incidence of VI was calculated while considering the competing risk of 
death160. The competing risk regression model is an adaptation of the Kaplan-Meier method 
that takes into account two competing events; in this case the events would be either 
development of VI or death.  
Analyses adjusted for co-variables or potential confounders were performed using logistic 
regression (PROC LOGISTIC) and discrete logistic regression (PROC PHREG), with the use 
of time-dependent study (VI) and outcome variables (support service use, falls, fractures, 
depressive symptoms and cognitive decline), to compute odds ratios for participants with and 
without visual impairment.  
Multi State Markov (MSM) package in R version 2.13.0161 (R Foundation for Statistical 
Computing, Vienna, Austria) was used for analysis for Chapter 4 to estimate the probability 
of transition from one VI state to another within a specific time period. This model uses data 
which is usually right censored in tradition analyses of longitudinal data. As many diseases 
such as visual impairment can improve or worsen over the course of a disease, this model can 
describe dynamic changes over time. All models were adjusted for age and sex. The model 
was represented by a four state system: no VI (State 1), mild VI (State 2), moderate/severe VI 
(State 3), and death (State 4). The estimated transition probability matrix P(t) within a given 
time (5-, 10- and 15-years) was extracted using the function “pmatrix.msm”. 
Association estimates are presented together with 95% confidence intervals (CIs).   
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 Section III 
Research Findings 
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Section III 
Part 1: Long-Term Incidence of Visual 
Impairment and Associated Factors 
 
Chapter 3: Long Term Changes in Visual Acuity in 
an Older Population 
 
        
 
 
 
 
 
 
 
 
 
Material in this Chapter has been published in 
Hong T, Mitchell P, Rochtchina E, Fong CS, Chia EM, Wang JJ. Long Term Changes in Visual Acuity in an 
Older Population over a 15-Year Period: the Blue Mountains Eye Study.  
Ophthalmology. 2013 Oct;120(10):2091-9. 
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ABSTRACT 
Purpose: To describe the change in visual acuity and incidence of visual impairment (VI) in 
an older population over a 15-year period. 
Methods: Of the 3654 participants of the Blue Mountains Eye Study (BMES) baseline 
examination during 1992-1994, 1149 were re-examined during the 15-year follow-up 
between 2007 and 2010. Best-corrected visual acuity (VA) by means of subjective refraction 
was measured with a logarithm of the minimum angle of resolution (LogMAR) chart using 
Early Treatment Diabetic Retinopathy Study (ETDRS) methods at each examination. 
Unilateral VI was defined as VA <6/12 and blindness as VA <6/60 in the worse eye. Incident 
bilateral VI and blindness was determined according to VA in the better eye at the 15-year 
visits. Doubling of the visual angle was defined as a loss of 15+ letters from baseline to the 
15-year visit. Halving of the visual angle was defined as a VA improvement of 15+ letters 
over the same period. Causes of VI were determined at examination, by photographic grading 
and from medical records. 
Results: Cumulative 15-year incidence of unilateral and bilateral VI was 12.3% and 5.2%, 
respectively, and for unilateral and bilateral blindness, was 3.7% and 0.9%, respectively. 
These incidence rates increased significantly with increasing age (p < 0.01). Doubling and 
halving of the visual angle occurred in 6.9% and 1.6% of participants, respectively. 
Cataract accounted for the majority (48.5%) of unilateral and bilateral incident VI, followed 
by age-related macular degeneration (AMD) (26.9%). AMD accounted for the majority of 
unilateral and bilateral incident blindness (56.9%), followed by cataract (20.7%).  
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Conclusions: These data provide population-based estimates of the cumulative 15-year 
incidence of visual changes in an older population. The cumulative incidence of blindness 
accounting for competing risk of death in our population was similar to that of the Beaver 
Dam Eye Study (BDES) after age standardization. However, the cumulative incidence of VI 
was higher in the BDES compared to our population. This may partially be explained by a 
higher mortality rate among our population. 
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Background 
Previous population-based studies have provided important data on the prevalence and causes 
of visual impairment (VI) in older persons14-24. The prevalence of VI is known to increase 
with age14;128;162. It has been shown to be associated with a loss of independence and an 
increased likelihood of reliance on community support services among affected older 
individuals38. VI has also been documented consistently to be associated with an increased 
risk of death14;122;128;130;163 in multiple older population samples. VI among the older 
population is thus a major condition demanding not only eye health care but also increases 
need for aged care services by affected individuals38. 
A number of studies have examined the long-term changes in vision and long-term incidence 
of VI among older persons in the USA14;24 and Europe82;84. The purpose of this report is to 
describe the 15-year change in visual acuity (VA) and the incidence of VI in the sample of 
older Australians attending the Blue Mountains Eye Study (BMES). This information may 
aid in the effective allocation of resources towards vision-related treatment, rehabilitation and 
prevention. 
Specific Methods 
Visual impairment definitions have been described previously in chapter 2, page 67.   VA 
used in this chapter refers to the best-corrected acuity after subjective refraction. 
A change in the number of letters read correctly was defined as the difference in the numbers 
of letters read between the 15-year and baseline examinations. Deterioration or doubling of 
the visual angle was defined as a loss of 15+ letters read correctly in the better eye from 
baseline to the 15-year visits. Improvement in vision (halving of the visual angle) was 
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defined if there was an improvement of 15+ letters read correctly over the same period. Eyes 
were at risk of deteriorating or improving VA (doubling or halving the visual angle) if their 
baseline VA was light perception or better, or if the baseline VA was 55 or less letters, 
respectively. 
Causes of Visual Impairment 
Cataract was diagnosed during the dilated slit lamp examinations and also recorded during 
lens photographic grading. AMD was diagnosed at the time the dilated fundus examination 
was conducted and confirmed by retinal photographic grading. Glaucoma was diagnosed 
when glaucomatous field loss was detected, based on repeated visual field tests where the 
visual field defect corresponded to optic disc changes, consistent with typical glaucomatous 
cupping 159. 
The primary cause of VI was defined as the condition which explained at least 50% of the 
vision loss. This was confirmed by review of the participant’s photographs and medical 
records. Cases where there was no obvious cause or where multiple causes were present were 
reviewed by an Ophthalmologist (PM) to determine the primary cause. 
Statistical Analysis 
SAS (Version 9, SAS Institute Inc, Cary, NC) was used for all analyses, and age was defined 
as age at baseline. Cumulative 15-year incidence was calculated while considering the 
competing risk of death160. The competing risk regression model is an adaptation of the 
Kaplan-Meier method that takes into account two competing events; in this case the events 
would be either development of VI or death. Persons eligible for inclusion in analyses 
contributed information up to the time when either of these two events occurred. Persons 
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were considered as censored when reasons other than death prevented them from 
participation in the follow-up examinations. Multivariable-adjusted analyses were performed 
with the following co-variables in the model: age, sex, employment status, marital status, 
education, previous medical history, smoking status and alcohol consumption. 
The incidence rates of VI and blindness reported by the Beaver Dam Eye Study (BDES) were 
age-standardized to the BMES population for comparison. For this comparison, we used 
modified definitions of VI (VA ≤ 6/12) and blindness (VA ≤ 6/60) following the definitions 
used in the BDES.  
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Results  
The mean age of participants at baseline was 64.5 years, and 57.9% were female. Table 3.1 
shows the baseline characteristics of the 2572 participants who attended at least one follow-
up examination after the baseline. 
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Table 3.1: Baseline Characteristics of Participants in the Blue Mountains Eye Study: 15-year Follow-up Examinations 
 Participants with follow-up information  Non-participants 
 Attended the 15-year 
follow-up examinations 
Attended at least 1 follow-up 
examination (5, 10 or 15 years)  
Alive Dead 
Characteristics Crude % n Crude % n Crude % n Crude % n 
Total (BMES I, n = 3654) 31.4 1149 70.4 2572 22.3 815 7.3 267 
Age (years) at baseline         
<55 22.2 237 14.7 368 27.5 84 3.9 33 
55-64 48.45 517 37.1 928 42.2 129 13.6 115 
65-74 26.34 281 34.5 862 24.84 76 32 271 
75+ 3 32 13.7 343 5.6 17 50.5 428 
Sex, female 57.9 618 42.2 1056 62.8 192 51.4 435 
Education (trade certificate or higher) 66.0 682 60.6 1445 55.1 157 51.3 384 
Employment         
High prestige (Daniel’s Prestige Scale <5) 65.6 691 63.5 1558 63.8 190 57.6 465 
Receiving pension 38.1 397 53.4 1295 42.8 125 80.7 653 
Home ownership 93.3 986 90.9 2224 83.9 250 83.7 679 
Currently married 71.8 766 65.9 1648 62.4 191 53.1 450 
Visual impairment in worse eye         
Any (VA 6/12 or worse) 2.8 30 5.9 147 6.2 19 19.2 161 
Severe (VA 6/60 or worse) 0.8 9 1.8 45 3.3 10 9.2 77 
History of         
Stroke 1.9 20 3.3 83 7.8 24 24.1 204 
Heart Disease (AMI or angina) 10.2 109 14.3 358 3.0 9 12.1 102 
Hypertension 35.2 375 42.5 1063 41.8 128 53.6 454 
Diabetes 5.2 55 6.4 160 8.5 26 11.6 98 
Cancer 6.3 67 7.4 186 6.2 19 12.4 105 
Smoking status         
Non-smoker 54.8 572 51.24 1239 42.5 124 43.4 335 
Previous smoker 32.9 343 13.2 319 34.6 101 38.5 297 
Current smoker 12.3 128 35.6 860 23.0 67 18.1 140 
Heavy Drinker (>4 drinks per day) 3.3 34 3.8 91 3.8 11 3.4 26 
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The overall mean decrease in number of letters read correctly over the 15 years was similar in  
right and left eyes (-6.9 and -6.8 letters respectively); there was an inverse relationship 
between reduction in mean numbers of letters read correctly from baseline to the 15-year 
examinations and age, shown in Figure 3.1.  There was no significant sex difference in the 
changes in numbers of letters read correctly in either right or left eyes (p = 0.97 and p = 0.25 
respectively). 
 
 
Figure 3.1: Mean Change in Number of Letters Read Correctly in Right and Left Eyes by 
Age between Baseline and 15-year Follow-up 
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The 15-year cumulative incidence of bilateral VI was 5.2% (119 participants), and varied 
from 0.4% in those aged <55 years to 10.5% in those aged ≥75 years at baseline. The 
incidence of bilateral blindness was 0.9% (21 participants), and varied from 0% in those aged 
<55 years to 1.7% in those aged ≥75 years at baseline. Women were more likely than men to 
have bilateral VI (6.8% vs. 3.4%, age-adjusted p=0.02) and bilateral blindness (1.2% vs. 
0.5%, age-adjusted p=0.09). The incidences of VI and blindness were strongly age-related in 
both men and women (p values <0.001) (Table 3.2). 
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Table 3.2: Incidence of Bilateral Visual Changes by Age at Baseline and Sex in the Blue Mountains Eye Study 
* Doubling of the visual angle was defined as a loss of 15 letters or more in the better eye at follow-up visits 
† Incidence of visual impairment was defined a visual acuity < 6/12 at follow-up in the better eye when both eyes were ≥ 6/12 at baseline examination 
‡ Incidence of severe visual impairment was defined as visual acuity < 6/60 at follow-up in the better eye when both eyes were ≥ 6/60 at baseline examination 
§ Halving of the visual angle was defined as a gain of 15 letters or more in the worse eye at the follow-up visit 
 Doubling 
of the Visual Angle* 
Visual Impairment† Blindness ‡ Halving 
of the Visual Angle§ 
Age (years) At risk % P for 
trend 
At risk % P for 
trend 
At risk % P for 
trend 
At risk % P for 
trend 
Female 
<55 217 2.6  212 0.7  217 0.0  118 2.7  
55-64 564 3.6  541 2.1  559 0.3  365 1.0  
65-74 579 11.8  534 11.5  567 2.0  475 1.5  
75+ 375 12.3  238 13.6  338 2.4  365 1.4  
Total 1735 8.0 <0.001 1525 6.8 <0.001 1681 1.2 <0.001 1323 1.4 0.43 
Male 
<55 170 1.4  165 0.0  167 0.0  66 0.0  
55-64 441 5.2  427 2.9  434 0.3  231 2.2  
65-74 464 6.0  413 3.7  447 0.5  340 2.1  
75+ 294 8.1  195 7.0  264 0.8  279 1.9  
Total 1369 5.6 <0.001 1200 3.4 <0.001 1312 0.5 0.008 916 1.9 0.032 
All 
<55 387 2.0  377 0.4  384 0.0  184 1.7  
55-64 1005 4.3  968 2.5  993 0.3  596 1.4  
65-74 1043 9.0  947 7.7  1014 1.3  815 1.8  
75+ 669 10.4  433 10.5  602 1.7  644 1.6  
Total 3104 6.9 <0.001 2725 5.2 <0.001 2993 0.9 <0.001 2239 1.6 0.038 
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The 15-year cumulative incidence of unilateral VI was 12.3% (293 participants), and varied 
from 3.4% in those aged <55 years to 15.4% in those aged ≥75 years at baseline. The 
incidence of unilateral blindness was 3.7% (95 participants), and varied from 1% in those 
aged <55 years to 6.9% in those aged ≥75 years at baseline. Women were more likely than 
men to develop unilateral VI (13.3% vs. 10.8%) and blindness (4.7% vs. 2.6%), however 
these differences were not statistically significant after adjusting for age (p = 0.5 and p = 0.1) 
(Table 3.3). 
The cumulative incidence of any VI was 17.3% (412 participants), and incidence of blindness 
in any eye 4.6% (116 participants). As expected, women had a higher incidence of any VI 
(19.7% vs. 14.2%, age-adjusted p = 0.06) and blindness (5.9% vs. 3.1%, age-adjusted 0.03) 
compared to men (Table 3.3). 
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Table 3.3: Incidence of Unilateral and Any Visual Impairment by Age at Baseline and Sex in the Blue Mountains Eye Study  
 Unilateral Any 
 Visual Impairment* Blindness† Visual Impairment‡ Blindness§ 
Age (years) At risk % P for 
trend 
At risk % P for 
trend 
At risk % P for 
trend 
At risk % P for 
trend 
Female 
<55 212 2.6  217 1.2  212 3.3  217 1.2  
55-64 541 10.6  559 2.3  541 12.5  559 2.5  
65-74 534 18.7  567 6.5  534 29.2  567 8.5  
75+ 238 17.4  338 8.4  238 30.6  338 8.7  
Total 1525 13.3 <0.001 1681 4.7 <0.001 1525 19.7 <0.001 1681 5.9 <0.001 
Male 
<55 165 4.4  167 0.8  165 4.4  167 0.8  
55-64 427 10.1  434 1.9  427 12.9  434 2.2  
65-74 413 13.3  447 2.6  413 16.9  447 3.1  
75+ 195 12.7  264 5.1  195 19.4  264 5.9  
Total 1200 10.8 <0.001 1312 2.6 <0.001 1200 14.2 <0.001 1312 3.1 <0.001 
All 
<55 377 3.4  384 1.0  377 3.8  384 1.0  
55-64 968 10.4  993 2.1  968 12.7  993 2.4  
65-74 947 16.3  1014 4.6  947 23.5  1014 5.9  
75+ 433 15.4  602 6.9  433 25.5  602 8.6  
Total 2725 12.3 <0.001 2993 3.7 <0.001 2725 17.3 <0.001 2993 4.6 <0.001 
 
* Incidence of unilateral visual impairment was defined as visual acuity < 6/12 at follow-up in only one eye (worse eye) when both eyes were ≥ 6/12 at baseline examination 
† Incidence of unilateral blindness was defined as visual acuity < 6/60 at follow-up in only one eye (worse eye) when both eyes were ≥ 6/60 at baseline examination 
‡ Incidence of any visual impairment was defined as having at least one eye at risk of developing visual impairment (visual acuity < 6/12) at baseline and the at risk eye  developing visual 
impairment at the follow-up examination 
§ Incidence of any blindness was defined as having at least one eye at risk of developing blindness (visual acuity < 6/60) at baseline and the at risk eye  developing blindness at the follow-up 
examination 
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 Doubling of the visual angle occurred in 183 participants (6.9%) based on the better eye, 
which was significantly associated with age in both men and women (p <0.001).  Halving of 
the visual angle occurred in 34 participants (1.6%) based on worse eye VA, and there was no 
significant association of halving the visual angle with age in either sex. Of these 34 
participants, 20 (59%) had undergone cataract surgery during the follow-up period. 
Table 3.4 shows a comparison of the incidence of VI between our study and BDES14 findings 
using the modified definition of VI and blindness, after direct standardization to the age 
distribution of the BMES population. Incidences of VI were higher in the BDES population 
(11.1%) compared to our population (6.4%), after adjusting for competing risk of death. 
However, the incidences of blindness were similar among the BDES population (1.2%) and 
our population (1.1%) Similar sex differences and age-related trends in incidences were also 
observed in the BDES population. 
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Table 3.4: 15–year Incidence of Visual Impairment and Blindness accounting for the competing risk of death by Age and Sex in the Blue 
Mountains Eye Study Compared to the Beaver Dam Eye Study   
 Visual Impairment Blindness 
 Blue Mountains Eye Study Beaver Dam 
Eye Study 
Standardized to 
Blue Mountains 
Eye Study 
Blue Mountains Eye Study Beaver Dam 
Eye Study 
Standardized to 
Blue Mountains 
Eye Study 
Age at 
baseline 
(Years) 
 
At 
Risk 
 
Crude 
% 
95% 
Confidence 
Interval 
 
At 
Risk 
 
Crude 
% 
% 
(95% Confidence 
Interval) 
 
At 
Risk 
 
Crude 
% 
95% 
Confidence 
Interval 
 
At 
Risk 
 
Crude 
% 
% 
(95% Confidence 
Interval) 
Female             
<55 211 0.7  661 1.5  217 0.0  667 0.2  
55-64 536 3.1  574 5.6  559 0.5  578 0.2  
65-74 523 12.6  569 18.4  565 2.3  598 0.9  
75+ 226 15.7  270 29.7  335 3.5  327 5.0  
Total 1496 7.8 6.3-9.3 2074 10.2 13.1 (11.6-14.6) 1676 1.3 0.9-2.3 2170 1.0 1.4 (0.9-3.4) 
Male             
<55 165 0.0  586 1.4  167 0.0  588 0.2  
55-64 424 4.3  507 2.8  433 0.3  510 0.0  
65-74 405 4.8  436 12.6  446 0.5  447 1.6  
75+ 182 10.4  185 18.5  263 1.2  211 1.8  
Total 1176 4.8 3.5-6.1 1714 6.0 8.4 (7.1-9.7) 1309 0.5 0.2-1.0 1756 0.6 0.9 (0.2-0.9) 
All             
<55 376 0.4  1247 1.4  384 0.0  1255 0.2  
55-64 960 3.6  1081 4.3  992 0.4  1088 0.1  
65-74 928 8.9  1005 15.9  1011 1.5  1045 1.2  
75+ 408 13.3  455 25.1  598 2.5  538 3.7  
Total 2672 6.4 5.4-7.4 3788 8.3 11.1 (10.1-12.1) 2985 1.1 0.7-1.5 3926 0.8 1.2 (0.7-2.4) 
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 Figure 3.2 presents the proportions of incident cases by primary attributable causes for any 
VI and blindness in any eye (either first or second eye). Cataract accounted for the majority 
(48.5%) of any VI, followed by age-related macular degeneration (AMD) (26.9%). However, 
AMD was responsible for the majority of any blindness cases (56.9%) followed by cataract 
(20.7%). Bilateral AMD was responsible for 71.4% of bilateral blindness. 
 
 
 
Figure 3.2: Causes of Any (Unilateral or Bilateral) Visual Impairment and Blindness 
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Discussion  
In our study the overall cumulative incidence of VI and blindness over the 15-year period 
was 5.2% and 0.9%, respectively. Women had approximately twice the incidence of any 
impairment when compared to men. The age-related increasing trend in incident VI was 
consistent in both sexes. Cataract and AMD were predominantly the primary causes of VI 
and blindness in this population.  
Our report from the BMES cohort complements previously findings from the BDES14, which 
is the only other study reporting 15-year longitudinal data on vision changes among older 
participants. Both studies included similar samples drawn from older, predominately white 
populations. The overall mean numbers of letters read correctly were similar between the two 
study populations. The BDES reported a mean decrease of -5.4 (SD=12.5) and -7.1 
(SD=13.7) in right and left eyes respectively over 15 years, compared to the corresponding 
mean decreases of -6.9 (SD=13.6) and -6.8 (SD=13.3) letters for the two eyes, respectively, 
in our study. However, the cumulative incidence of VI accounting for the competing risk of 
death was substantially higher in the BDES than the BMES across all age groups (Table 3.4). 
The overall mortality rate was substantially higher in our study sample (43.6%) compared to 
the BDES (29.8%). Competing risk of death may partially explain the discrepancies in VI 
incidences between the two studies as the BDES had a younger population at baseline. 
Without adjusting for the competing risk of death in the analysis, the cumulative incidence of 
VI in our population changed from 6.4% to 9.6%, which is similar to the estimates from the 
BDES population (11.1%).  
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Overall doubling and halving of the visual angles were also similar between the two studies: 
doubling of the visual angle occurred in 6.9% and 7.2%, and halving of the visual angle 
occurred in 1.6% and 1.9%in the BMES and the BDES, respectively.   
A number of longitudinal studies have examined long-term changes in vision in older 
persons. The Barbados Eye Study (BES)83 reported 9-year incidence data from a 
predominately African American population aged 40 to 84 years at baseline, using the same 
VI definitions as the BDES14. The BES found a slightly higher incidence rate of VI, but 
double the incidence of blindness (6.4% and 2.1%, respectively) compared to our study 
estimates, albeit over a shorter follow-up period than our study follow-up period. Using 
World Health Organisation definitions (VA <6/21 in the better eye for VI, and VA <6/120 for 
blindness), two population-based longitudinal studies in Italy reported VI incidence data 
among adults. The Ponza Eye Study84 reported that12-year incidence of bilateral VI was 
3.9%, and bilateral blindness was 0.7% in participants aged 40+ years at baseline. The 
Priverno Eye Study82 reported that7-year incidence of bilateral VI was 1.3% and bilateral 
blindness was 0.2% in participants aged between 45 and 69 years at baseline. Both studies 
had acceptable follow-up rates of 70.7%84 and 81.4%82, respectively.  
Our data confirm an inverse relationship between increasing age and worsening VA over the 
15-year period. The higher incidence of VI and blindness in the oldest age group is consistent 
with higher prevalence rates of macular degeneration and cataract164;165 in this age group. 
Consistent with previous reports that women were more likely to have VI, both by 
prevalence16;21;23 and incidence14;82, we observed the same sex difference in the long-term 
incidence of VI and blindness. This is likely due to women having greater longevity than 
men, the latter having mortality as a competing risk that could have occurred before VI/ 
blindness developed or was detected at the study follow-up visits166;167. 
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The estimated VI and blindness incidences could have been underestimated in our 
population. Participants who did not return to any of the follow-up visits were almost twice as 
likely to be current smokers at baseline, compared to participants who attended the 15-year 
follow-up examinations. Smoking has consistently been documented to be associated with an 
increased risk of AMD150;168, the leading cause of blindness in our and other study 
populations. Participants who did not attend any follow-up examinations (including those 
who died) after the baseline examination had higher prevalence of VI and blindness at 
baseline. This could have led to an underestimated incidence of blindness, but should not 
have affected the estimation of incidence of VI, as these prevalent VI cases were no longer at 
risk of VI. 
Of eyes that developed blindness over the 15-year period, late AMD was found to be the 
primary cause of incident blindness in both the BMES (56.9%) and the BDES (52%). 
Cataract was found to be the primary cause of blindness in 20.7% of eyes in the BMES and 
12% of eyes in the BDES14. 
Vision screening may help detect vision threatening conditions earlier. However, several 
trials reported that vision screening in older participants (>75 years) did not lead to 
improvement in vision or vision-related quality of life138;169.  
In summary, our estimated cumulative incidences of VI were lower than those reported from 
the BDES and BES, while our study samples had a higher mortality rate, a competing risk to 
VI development. Our study showed that age was strongly associated with the development of 
VI in this older population, likely due to the increasing prevalence of many common ocular 
diseases associated with aging. Women were twice as likely as men to develop VI and 
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blindness, even after adjusting for age, which is likely a result of different age-specific 
mortality rates between men and women.  
Based on the population estimates from the Australian Bureau of Statistics170 (2006), the U.S. 
Census Bureau171 (2000) and the VI incident rates from our data, we estimate the number of 
older persons aged 50+ years with VI will increase from 480,000 to 1 million in Australia and 
from 3 million to 18 million in the USA. This translates to an estimated demand for 
additional 23,000 and 180,000 cataract surgical procedures in the next 15 years in the two 
countries, respectively, in order to treat unilateral and bilateral new cases of blindness due to 
cataract. 
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Section III 
Part 1: Long-Term Incidence of Visual 
Impairment and Associated Factors 
 
Chapter 4: Longitudinal transition rates of Visual 
Impairment States among Older People 
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Abstract 
Purpose: To estimate transitional probabilities of visual impairment (VI) states in an older 
Australian cohort. 
Methods: Of 3654 baseline participants of the Blue Mountains Eye study, 2334, 1952 and 
1149 were re-examined after 5-, 10- and 15-years. VI was defined as presenting visual acuity 
(VA) in the better eye and was categorised into three states; State 1 (VA ≥ 6/12), State 2 (VA 
<6/12 but ≥6/24), and State 3 (VA <6/24). Deaths (State 4) were confirmed via data linkage 
to the Australian National Death Index. Multi-state hidden Markov models were used to 
estimate the transitional probabilities and average life expectancy associated with each VI 
state, adjusting for age and sex.  
Results: The probability of improving vision from State 2 to State 1 was 0.43, 0.44 and 0.39 
at the 5-, 10- and 15-year time points, respectively. The probability of improving vision from 
State 3 to State 1 was 0.08 at the 5-, and was 0.10 at both 10- and 15-year. The probability of 
worsening vision from State 1 to 2 and from State 2 to 3 was relatively low, with 0.07 and 
0.06 at 5-, 0.07 and 0.03 at 10-, and 0.06 and 0.02 at 15-year, respectively.  
Conclusions: In this older Australian cohort aged 50+ years, we found that approximately 
40% of those with mild VI improved to normal, and 10% of those with moderate/severe VI 
improved to normal, reflecting successful outcomes of eye healthcare services for older 
people.   
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Background 
Traditionally, risk factors associated with vision impairment (VI) are determined with the use 
of association estimates such as odds ratios or relative risks10;121;123. However, the dynamic 
changes in VI states and the time associated with each state cannot be assessed using 
traditional regression models.  
Multi-State Markov (MSM) model estimates the probability of disease state transitions using 
information which is usually right censored over the course of the disease. As vision can 
improve or worsen, it is informative to describe dynamic changes of disease states over time, 
particularly for conditions that are treatable such as VI.  
The purpose of this paper is to illustrate the longitudinal dynamic changes in VI states in an 
older population-based sample, and estimate the probability of improvement, deterioration 
and death from each VI state. A better picture of the dynamic changes in VI levels among 
older persons may also be useful to health policy planning for prevention and services 
provision. 
Specific Methods 
Visual Impairment 
VI was defined as presenting VA in the better eye and categorised into three states; State 1: 
No VI, defined as VA ≥ 6/12 (≥39 letters read correctly), State 2: Mild VI, defined as VA 
<6/12 and ≥6/24 (24-38 letters read correctly), and State 3: Moderate to Severe VI, defined as 
VA <6/24 (<23 letters read correctly). 
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To identify and confirm participants who died (State 4) after the baseline examination, 
demographic information of the participants were cross-matched with Australian National 
Death Index (NDI) data for deaths to the end of 2007. Information provided by family 
members during the follow-up period about any deaths was also included. Date of death and 
causes of death were also provided by the NDI. 
Statistical Analysis 
MSM package in R version 2.13.0161 (R Foundation for Statistical Computing, Vienna, 
Austria) was used to estimate the probability of transition from one state to another within a 
specific time period. All models were adjusted for age and sex. Participants were censored if 
no VA data was available at a follow-up examination. The model was represented by a four 
state system: no VI (State 1), mild VI (State 2), moderate/severe VI (State 3), and death 
(State 4). All possible transitions are shown in Figure 4.1. Participants in the middle two 
states could transition to either a better or a worse state. The estimated transition probability 
matrix P(t) within a given time (5-, 10- and 15-years) was extracted using the function 
“pmatrix.msm”. 
Simple statistics included chi-squared (χ²) test to compare proportions of categorical 
variables, and a p value of less than 0.05 was considered statistically significant. 
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Figure 4.1: A matrix of Multi-state Markov model depicting possible transitions between 
different states of vision impairment (VI) and death. 
 
 
 
 
Rectangular boxes represent the four states and the arrows represent transitional directions 
between different states. Transitions could occur in both directions for states of mild VI and 
moderate/severe VI. The three colours (white, grey and black) for arrows and oval boxes 
represent transition to better, worse VI state or death, respectively. 
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Results 
Of the 3654 baseline participants, 1606 had died by the 15-year follow-up examination. At 
baseline, 334 of the 3654 (9.2%) had mild VI and 69 (1.9%) had moderate/severe VI.  Of the 
2334 and 1952 participants who attended the 5- and 10-year follow-up visits, 194 (8.4%) and 
175 (9.8%) had mild VI, and 40 (1.7%) and 41 (2.3%) had moderate/severe VI in their better 
eyes, respectively, at the 5- and 10-year follow-up time points.  Of the 1149 participants who 
attended the 15-year follow-up examination, 86 (8.1%) had mild VI and 36 (3.4%) had 
moderate/severe VI at the 15-year follow-up time point. The mean follow-up time of this 
cohort was 15.6±0.6 years. Table 4.1 presents the distributions of participants by VI state and 
by sex at baseline and each follow-up examination time point. Women were consistently 
found to have a higher prevalence of moderate to severe VI compared to men at all 
examination time points. 
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Table 4.1: Distribution of visual impairment (VI) level by gender at each examination time 
point 
Visual Impairment 
level 
All 
n (%) 
Women 
n (%) 
Men 
n (%) 
P value 
Baseline   
None 3246 (89.0) 1824 (88.2) 1422 (90.0) 0.08 
Mild 334 (9.2) 198 (9.6)  136 (8.6)  0.32 
Moderate/severe 69 (1.9) 47 (2.3) 22 (1.4) 0.05 
5-year follow-up   
None 2085 (89.9) 1182 (88.5) 903 (91.9) <0.01 
Mild 194 (8.4) 125 (9.4) 69 (7.0) 0.04 
Moderate/severe 40 (1.7) 29 (2.2) 11 (1.1) 0.05 
10-year follow-up   
None 1570 (87.9) 910 (86.3) 660 (90.2) 0.01 
Mild 175 (9.8) 111 (10.5) 64 (8.7) 0.21 
Moderate/severe 41 (2.3) 33 (3.1) 8 (1.1) <0.01 
15-year follow-up   
None 940 (88.5) 535 (87.1) 405 (90.4) 0.10 
Mild 86 (8.1) 52 (8.5) 34 (7.6) 0.60 
Moderate/severe 36 (3.4) 27 (4.4) 9 (2.0) 0.03 
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Table 4.2 presents the age and sex adjusted projected probability of possible transitions 
between states at 5-, 10- and 15-years using data from observed states at prior and a specific 
follow-up visit. After age- and sex-adjustment, the probability of a participant with mild VI at 
baseline improving to no VI was approximately 40% (43%, 44%, and 39% at 5-, 10- and 15-
year time points, respectively). The probability of a participant with moderate/severe VI at 
baseline improving to no VI was approximately 10% (8%, 10%, and 10% at 5-, 10- and 15-
year time points, respectively).  
The probability of a participant with no VI at baseline worsening to mild VI was about 7% 
(7%, 7% and 6%, respectively, at 5-, 10- and 15-year time points, respectively). Similarly, 
there was a low probability of a participant with mild VI at baseline worsening vision to 
moderate/severe VI (6%, 3% and 2%, respectively, at 5-, 10- and 15-year time points, 
respectively).  
The probability of death among participants with moderate/severe VI at baseline was between 
64-87% (64%, 81%, and 87% at 5-, 10- and 15-year time points, respectively). The 
probability of death among participants with no VI at baseline was between 13-36% (13%, 
25%, and 36%, at 5-, 10- and 15-year time points, respectively), after adjusting for age and 
sex (Table 4.2). Figure 4.2 presents the goodness of fit of the MSM models by comparing 
the observed and expected proportions in each state after adjusting for age and gender. The 
predicted number of participants who died is under-estimated by the model after about 10 
years. Similarly, the number of participants without VI is over-estimated after approximately 
10 years. 
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Table 4.2: Age and sex adjusted projected probabilities* of possible transitions between 
visual impairment states and death (at 5-year, 10-year and 15-year time points) shown in 
separated panels.  
Estimated transitional probabilities at 5 year time point 
 Status at BMES† II 
 
VI status at baseline 
No VI Mild VI Moderate/ 
severe VI 
Death 
No VI 0.80 0.07 0.01 0.13 
Mild VI 0.43 0.22 0.06 0.29 
Moderate/severe VI 0.08 0.07 0.22 0.64 
Estimated transitional probabilities at 10 year time point 
 Status at BMES† III 
 
VI status at baseline 
No VI Mild VI Moderate/ 
severe VI 
Death 
No VI 0.67 0.07 0.01 0.25 
Mild VI 0.44 0.08 0.03 0.45 
Moderate/severe VI 0.10 0.03 0.05 0.81 
Estimated transitional probabilities at 15 year time point 
 Status at BMES† IV 
 
VI status at baseline 
No VI Mild VI Moderate/ 
severe VI 
Death 
No VI 0.56 0.06 0.01 0.36 
Mild VI 0.39 0.05 0.02 0.55 
Moderate/severe VI 0.10 0.02 0.02 0.87 
 
*Maximum likelihood estimates used data from observed states (e.g. the projected probability of transitions at 
10-years used data from observed states at the 5- and 10-year follow-up visits). 
†Blue Mountains Eye Study 
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Figure 4.2: Estimated goodness of fit of a multi-state model. Observed numbers of 
individuals occupying a state at a series of time plotted against forecasts from the fitted 
model for each state. 
State 1 = no visual impairment 
State 2 = mild visual impairment 
State 3 = moderate/severe visual impairment 
State 4 = Death   
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Discussion 
The MSM model provides perspective estimates for changes in VI states of this older 
Australian cohort.  We found a low probability of worsening vision (approximately 7%) over 
a 15-year period, and a moderate probability of improving vision from mild VI to no VI 
(around 40%), reflecting the outcome of eye health care interventions among older people 
with VI. We also found a relatively high probability of death (64-87%) among participants 
with moderate to severe VI compared to those with no VI (13%-36%) over the 15-year 
period.  
Previously, other large population studies have reported between 1 and 16% incidence of 
worsening vision (<6/12) up to a period of 20 years 14;24;68;72;79;84;87;162. Our findings of 
approximately 7% probability of worsening vision from either no VI or mild VI after 
controlling for the effect of age and sex are in keeping with these previous findings. 
The moderate (40%) probability of an improvement in vision from mild VI to no VI is likely 
the results of multiple reasons. The most likely explanations are cataract surgery, posterior 
sub-capsular opacity laser treatment and correction of refractive errors. This finding suggests 
that earlier interventions and rehabilitation of mild VI is in place and effective in Australia. 
The probability of improvement from moderate/severe VI to no VI was about 10%, which 
could partly be due to the fact that treatments for causes of moderate/severe VI other than 
cataract and refractive errors may not be effective in vision restoration at the time of this 
study, due to the nature of the underlying disease (e.g. late stage AMD and diabetic 
retinopathy). This reinforces the benefit of earlier interventions and prevention of VI among 
older persons40626, 45612]. 
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Previous reports have found that the more severe the level of VI, the higher the risk of death 
after adjusting for other known risk factors associated with mortality172;173. We found a high 
probability (up to 87%) of death among participants with moderate/severe VI over the 15-
year period, after adjusting for age and sex. Other co morbidities associated with 
moderate/severe VI might contribute to this observation, including low self-rated health, 
frailty, falls, depression and dementia174-177. Many causes of VI are also associated with other 
systemic conditions that are associated with increased mortality, including diabetes, 
cardiovascular disease, and inflammatory conditions such as arthritis178-186.  
Previous studies using pathway analysis (structural equation modelling) found that VI was 
both directly and indirectly associated with mortality after adjusting for other co-
morbidities128;187. Due to small numbers of participants with moderate/severe VI in our cohort 
sample, we could not adjust for more co-variables in the MSM model. Therefore the 
probabilities of death derived from our age-and sex-adjusted MSM model could be 
confounded by other co-morbidities, and should be interpreted with caution.  
In summary, among older persons with mild visual impairment, there was approximately 
40% probability of improving to no VI, and among those with moderate/severe VI, 10% 
probability of improving to no VI, over the course of 15 years. The estimated projected 
probabilities of transitions between VI states were relatively stable over the three time points. 
These data provide a picture of dynamic changes in terms of visual impairment states among 
older people. Regular eye health care services to detect and treat causes of visual impairment 
may help prevent further deterioration of visual disorders and maximize the probability of 
having good vision and good quality of life at older ages. 
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Section III 
Part 1: Long-Term Incidence of Visual 
Impairment and Associated Factors 
 
Chapter 5: Adherence to Australian Dietary 
Guidelines and the 10-year Cumulative Incidence of 
Visual Impairment 
 
 
 
 
 
 
 
Material in this Chapter has been published in 
Hong T, Flood V, Rochtchina E, Mitchell P, Russell J, Wang JJ. Adherence to dietary guidelines and the 10-
year cumulative incidence of visual impairment: the Blue Mountains eye study. 
American Journal of Ophthalmology. 2014 Aug;158(2):302-8. 
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Abstract 
Purpose: To assess whether adherence to dietary guidelines at baseline is associated with the 
incidence of visual impairment among older persons after 10 years. 
Methods: A population-based cohort of 3654 participants of the Blue Mountains Eye Study 
were examined at baseline, and re-examined after 5- and 10-years. The incidence of visual 
impairment (VI) was defined as best corrected visual acuity (VA) <6/12 at follow-up in one 
or both eyes. Dietary information was obtained at baseline using a validated food frequency 
questionnaire (FFQ). Total Diet Scores (TDS) were calculated based on the Australian diet 
quality index. TDS includes components of diet quality; poor dietary habits; and energy 
balance.  Discrete logistic regression models with time-dependent outcome variables were 
used to calculate hazard risk ratios (HR) and 95% confidence intervals (CI) associated with 
incidence of VI for each unit/quartile increase in TDS, adjusting for potential confounders. 
Results: Of the 3654 baseline participants, 1963 had up to 10 years follow-up with 
completed FFQs. With each unit increase in TDS, the risk of VI decreased (HR 0.94, 95%CI 
0.88-1.00).  The risk of developing VI was lower among participants in the highest compared 
to the lowest TDS quartile (HR 0.71, 95%CI 0.47-1.05). This association was significant 
among participants aged 65+years (HR 0.63, 95%CI 0.38-0.98) but not those aged <65 years 
(HR 0.95, 95%CI 0.46-1.97). 
Conclusions: Compliance to dietary guidelines was associated with a decreased long-term 
risk of VI in this sample of Australians aged 65+years. 
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Background 
Different dietary guidelines and diet quality indices exist worldwide and vary according to 
different populations and diseases. The two most frequently used diet quality assessment 
tools are the Healthy Eating index 188 and the Diet Quality Index189. An unhealthy diet and 
lifestyle that includes a high consumption of fat, sugar, salt, alcohol and smoking can 
accelerate aging and degenerative processes via increased oxidative stress, which may 
contribute to the development of cataract and age-related macular degeneration (AMD), the 
two main causes of VI and blindness in older people worldwide 190-194. However, to our 
knowledge, the association between overall diet quality and all cause VI has not been 
reported previously. 
This study aimed to investigate longitudinal associations between baseline diet quality, 
indicated by adherence to the Dietary Guidelines for Australian Adults 195, and the 10-year 
incidence of VI in the Blue Mountains Eye Study cohort. 
Specific Methods 
Visual impairment definitions have been described previously in chapter 2, page 67. VA 
used in this chapter refers to the best-corrected acuity after subjective refraction. 
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Dietary assessment 
The Total Diet Score (TDS) was developed based on a modified version of the Australian 
diet quality index 196 (Table 5.1), to assess adherence to the Dietary Guidelines for Australian 
Adults195, and the Australian Guide to Healthy Eating197. Development details of the total diet 
score have been published previously 198. Briefly, the total diet score is divided into 10 
components with a possible score of 0 to 2 per component. For example, a person who 
consumed fruit and vegetables more frequently, including a moderate variety of vegetables, 
scored a maximum score of 2 for this component. The dietary components of the total diet 
score considered intakes from the core food groups (vegetables, legumes and fruit; cereals; 
meat, and meat alternatives; milk, yogurt and cheese) and optimal food choices as 
recommended by the Australian Guide to Healthy Eating (whole grain cereals, lean red meat, 
low or reduced fat milk, low saturated fat intake, fish consumption as well as lower intakes of 
sodium, alcohol, sugar and extra foods that do not provide essential nutrients the body needs, 
e.g. energy dense nutrient poor foods (foods with high levels of fat, salt and sugar)). The 
recommended serves for each food group were taken from the Australian Guide to Healthy 
Eating197 with some exceptions, for example, 2 serves of fruit per day were replaced with 3 
serves per day and 5 serves of vegetables per day replaced with 7 serves per day to adjust for 
self-reported overestimation, as suggested by a previous study 155. 
The non-dietary Australian Guide to Healthy Eating recommendation for preventing weight 
gain was also included as 1 of the 10 total diet score components. Half of this component was 
assigned to energy balance (the ratio of energy intake to energy expenditure) and the 
remaining half to leisure time physical activity. Physical activity levels were self-reported 
using questions from the Australian National Heart Foundation Risk Factor Prevalence 
Surveys (Risk Factor Prevalence Study Management Committee 1989)199. Walking, moderate 
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or vigorous activities were scored as Metabolic Equivalents as described by Craig et al 200and 
divided into tertiles.  
The sum of scores from the ten components was calculated for each person, with a maximum 
score of 20. Higher scores indicated greater adherence to the dietary guidelines. 
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Table 5.1: Total Diet scoring system based on the Australian Healthy Eating Guide. 
Dietary guideline/ 
component 
Score Component subscore Total 
score 
1. Eat plenty of vegetables, 
legumes and fruit 
Total vegetable 
serves/day 
 
 
 
Vegetable variety 
score/day 
 
 
 
 
Total fruit serves/day 
7 serves                                       0.5 
5·6 serves                                    0·4 
4·2 serves                                    0·3 
2·8 serves                                    0·2 
1·4 serves                                    0·1 
≥1 serve green                             0·1 
≥1 serve orange                           0·1 
≥1 serve of cruciferous                0·1 
≥1 serve of tuber or bulb             0·1 
≥0·5 serves of legumes                0·1 
 
3 serves                                        1 
2 serves                                        0·5 
2 
2. Eat plenty of cereals, 
preferably whole 
grain/meal 
Total cereals serves/day 
Women 
 
 
 
Men 
 
 
 
 
 
Whole-grain cereal 
serves/day 
Women 
 
 
 
Men 
 
4 serves                                        1 
3 serves                                        0·75 
2 serves                                        0·5 
1 serve                                         0·25 
6 serves                                        1 
5 serves                                        0·83 
4 serves                                        0·66 
3 serves                                        0·5 
2 serves                                        0·33 
1 serve                                         
0·166 
 
4 serves                                        1 
3 serves                                        0·75 
2 serves                                        0·5 
1 serve                                          
0·25 
6 serves                                        1 
5 serves                                        0·83 
4 serves                                        0·66 
3 serves                                        0·5 
2 serves                                        0·33 
1 serve                                         
0·166 
2 
3. Include lean meats, fish, 
poultry and/or alternatives 
Meat/alternative/day 
Lean red meat/week 
(i.e. > 0·428/day) 
≥1 serve                                       1·5 
≥3 serves                                      0·5 
2 
4. Include milk, yoghurts, 
cheese and/or alternatives 
Total dairy serves/day 
 
 
 
 
Ratio of skimmed/low 
fat (S/LF) intake: whole 
milk intake 
≥2–3 serves                                  1·5 
≥3–4 serves                                  1·0 
1–<2 serves                                  1·0 
>4 serves                                      0·5 
0–<1 serves                                  0 
S/LF>whole milk                         0·5 
S/LF=whole milk                         
0·25 
Whole milk>S/LF                        0 
2 
5. Limit saturated fat and 
Moderate total fat intake 
Percentage of energy from 
saturated fat 
 
Fish serves/week 
<10% energy                                1 
10–12% energy                            0·5 
>12% energy                                0 
≥ 2 serves                                     1 
1–<2 serves                                  0·5 
<1 serve                                        0 
2 
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 S/LF: skimmed/low fat, MET: metabolic equivalents 
  
6. Choose foods low in salt Na intake/day ≤ 40 mmol (920 mg)                    2 
> 40–≤100 mmol (920–2300 mg) 1 
>100 mmol (2300 mg)                 0 
2 
7. Limit alcohol intake if 
you choose to drink 
Alcohol intake/day 
Women 
 
 
Men 
 
≥0 g–<10 g                                   2 
≥10 g–<20 g                                 1 
≥20 g                                            0 
≥0g–<20 g                                    2 
20                                                 0 
2 
8. Consume only moderate 
amounts of sugars and 
foods with added sugars 
Percentage of energy 
from sugar 
<15% total energy                        2 
≥15–<20% total energy                1 
≥20% energy                                 0 
2 
9. Extra foods, not 
essential 
to provide nutrients and 
maybe high in salt, fat or 
sugar 
Extra food serves/day 
Women 
 
 
Men 
 
<2·5 serves                                    2 
2·5–<4 serves                                1 
>4 serves                                       0 
<3 serves/day                                2 
3–<5 serves                                   1 
≥5 serves                                       0 
2 
10.Prevent weight gain: be 
physically active and eat 
according to energy needs 
Ratio of energy intake to 
energy expenditure 
 
Physical activity (METs) 
0·76–1·24                                      1 
<0·76 or >1·24                              0 
 
Lowest tertile                                0 
Middle tertile                                0·5 
Highest tertile                               1 
2 
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Statistical analysis 
SAS 9.2 software (SAS Institute, Cary, NC) was used for statistical analyses. PROC 
LIFETEST was used to estimate the incidence rate of VI. Both continuous score data (per 
unit increase) and quartiles of TDS were used as independent variables and incidence of VI 
or blindness as dependent variables in analyses. Discrete logistic regression models (PROC 
PHREG) with a time-dependent outcome variable (VI) were used to estimate associations of 
incident VI or blindness with baseline TDS or TDS quartiles where quartile 1 (the group with 
the least adherence) of the TDS was the reference level. This model discrete logistic 
regression) allows the use of time information when VI was detected among participants who 
had attended one or both follow-up examination (5-year, 10-year follow-up visits). 
The detrimental effect of smoking on visual impairing eye diseases such as AMD has been 
previously been well documented. Participants who smoked were excluded in a 
supplementary analysis to eliminate the effect of this potential confounder on the association 
under investigation. 
VI has previously been found to be more frequent among participants older than 65 years 
compared to participants 65 years or younger in this cohort 201; hence we performed analyses 
stratified by age group to assess the association between TDS and VI in the two age groups 
separately (Figure 5.1). Analyses were adjusted for age, sex, history of diabetes or 
cardiovascular disease, smoking status, education and home ownership. The associations are 
presented as hazard risk ratios (HR) with 95% confidence intervals (CI). 
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Figure 5.1: 10-year incidence of visual impairment by quartiles of total diet score and 
age group 
 
Incidence rates were calculated by Kaplan-Meier estimates 
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Results 
Of the 3654 baseline participants, the food frequency questionnaire was attempted and 
returned by 3267 participants (89.4% response); of these 2897 were suitable for analysis 
(79.3% of participants). Among these participants, 1963 (67.8%) had been followed at the 
10-year follow-up examination and thus were included in this report.  
The baseline characteristics of participants who attended the 10-year follow-up examination 
compared to those who did not present to follow-up examinations are presented in Table 5.2. 
Participants who attended the 10-year follow-up examination were more likely to be female, 
and to have a younger age and a higher total diet score compared to participants who did not 
attend any follow-up visits. 
 
 
Table 5.2: Baseline characteristics of participants and non-participants of the 10-year follow-
up examination of the Blue Mountains Eye Study 
 
* SD=Standard deviation 
 Participants Non-participants P value 
Total numbers 1963 934  
Mean total diet score (range) 9.4 (9.3-9.5) 9.0 (8.9-9.1) <0.001 
Mean age in years (SD*) 63.4 (63.1-63.8) 69.4 (68.7-70.1) <0.001 
Female (%) 57.1 53.5 0.07 
Current Smoker (%) 12.6 17.3 <0.001 
Tertiary Education (%) 61.8 54.9 <0.001 
Married or de facto (%) 69.2 60.2 <0.001 
Mean Body Mass Index (SDa) 26.4 (26.2-26.6) 25.7 (25.4-26.0) <0.001 
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Baseline characteristics by quartile of TDS are presented in Table 5.3. Baseline total diet 
score ranged from a minimum score of 3.17 to a maximum of 15.40, out of a possible total 
score of 20. Women, non-smoking participants, and those reporting tertiary education had a 
higher mean total diet score. 
Cross-sectional analysis of baseline data showed that each unit increase in baseline total diet 
score was non-significantly associated with a lower prevalence of VI (adjusted HR 0.96, 95% 
CI 0.90-1.02). Participants in the highest TDS quartile had a non-significant lower prevalence 
of VI compared to those in the lowest TDS quartile (adjusted HR 0.78, 95% CI 0.53-1.15).  
Of the 1963 participants re-examined at the 10-year follow-up, we observed a 6% decrease in 
the 10-year risk of VI associated with per unit increase in baseline TDS (HR 0.94, 95% CI: 
0.88-1.00). Participants in the highest total diet score quartile at baseline had a 29% 
decreased risk of developing VI compared to those in the lowest quartile, although this 
difference was not statistically significant (adjusted HR 0.71, 95% CI 0.47-1.05) (Table 5.3). 
When participants who were current smokers were removed from the analysis, the 
association remained the same (adjusted HR 0.71, 95% CI 0.44-1.05). 
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Table 5.3: Baseline characteristics of participants who attended the 10-year follow-up examination of the Blue Mountains Eye Study (2002-
2004) by baseline Total Diet Score quartiles 
  
* Standard deviation 
† BMI = body mass index 
 Quartile 1 Quartile 2 Quartile 3 Quartile 4 
Total Number 488 493 495 487 
Mean total diet score (range) 6.6 (3.2-7.8) 8.6 (7.8-9.3) 10.1 (9.3-11.0) 12.2 (11.0-15.4) 
Mean age, years ( SD*) 62.5 (8.1) 63.8 (8.2) 62.9 (8.1) 64.6 (7.7) 
Female (%) 41.4 57.4 59.8 69.8 
Any Visual impairment (%) 12.4 11.2 9.0 9.2 
Smoking Status (%)     
Current 21.3 13.2 10.3 5.7 
Past 41.78 38.1 33.6 32.6 
Never 36.9 48.7 56.1 61.8 
Tertiary Education (%) 59.2 61.7 62.6 63.8 
Marital Status (%)     
Married or de facto 67.2 70.0 72.9 66.9 
Divorced or Separated 13.8 10.1 11.7 11.9 
Widowed 10.5 13.0 9.1 13.8 
Never Married 8.6 6.9 6.3 7.4 
Mean BMI† mean (SDa) 26.4 (4.4) 26.7 (5.6) 26.6 (4.3) 25.9 (4.2) 
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When analyses were conducted in subgroups of participants stratified by age ≤65 and >65 
years, we found that the reduced risk of VI associated with the highest TDS quartile, 
compared to the lowest quartile, was significant among participants aged >65 years (HR 0.61 
95% CI 0.38-0.98) but not among those aged ≤65 years (HR 0.97, 95% CI 0.41-1.97) (Table 
5.4). When total diet score data were analysed continuously, the same association pattern was 
evident in the older aged group only (HR 0.92, 95% CI 0.85-0.99 per unit increase) but not in 
the younger group (HR 0.98, 95% CI 0.86-1.12 per unit increase). When participants who 
were current smokers were excluded, the association estimates were HR 0.93, 95% CI 0.86-
1.01 per unit increase in the older age group and HR 0.97, 95% CI 0.84-1.11 per unit increase 
in the younger age group. We did not observe any significant associations between TDS and 
the incidence of blindness, either as a continuous (HR 0.97, 95% CI 0.83-1.14 per unit 
increase) or categorical variable (HR 0.71, 95% CI 0.27-1.83, highest versus lowest quartile). 
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Table 5.4: Associations between total diet score and the 10-year cumulative incidence of 
visual impairment 
 n Hazard 
Ratio* 
95% CI P value 
All     
Quartile 1 88 1.0 - - 
Quartile 2 82 0.73 0.49-1.08 0.11 
Quartile 3 78 0.69 0.46-1.03 0.07 
Quartile 4 86 0.71 0.47-1.05 0.09 
Per unit increase in TDS†  0.94 0.88-1.00 0.05 
≤65 years     
Quartile 1 33 1.0 - - 
Quartile 2 24 0.60 0.27-1.35 0.21 
Quartile 3 26 0.79 0.38-1.66 0.53 
Quartile 4 32 0.95 0.46-1.97 0.89 
Per unit increase in TDSb  0.98 0.86-1.12 0.79 
>65 years     
Quartile 1 55 1.0 - - 
Quartile 2 58 0.75 0.47-1.19 0.22 
Quartile 3 52 0.65 0.4-1.06 0.08 
Quartile 4 54 0.61 0.38-0.98 0.04 
Per unit increase in TDSb  0.92 0.85-0.99 0.03 
 
 
Quartile 1 (TDS 3.2-7.8), Quartile 2 (TDS 7.8-9.3), Quartile 3 (TDS 9.3-11.0), Quartile 4 (TDS 11.0-
15.4). 
  
* Adjusted for age, sex, education, home ownership, smoking status, cardiovascular disease and 
diabetes  
† TDS – Total Diet Score 
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Discussion 
In an older Australian cohort followed over a decade, we documented that higher levels of 
adherence to dietary guidelines, indicating higher scores of diet quality and a healthy 
lifestyle, was associated with a nearly 40% reduction (95% CI 2%-62%) in the long-term risk 
of VI among participants aged 65+ years, independent of known VI risk factors including 
smoking, education and diabetes.  These findings suggest the long-term benefits of higher 
diet quality to vision and the eye.  
The associations between overall diet quality and specific eye conditions have been 
previously reported with different dietary scores; however it has not been assessed for 
association with incidence of VI. Mares et al 202;203 found that a higher Healthy Eating Index 
score (highest vs. lowest quintile) had a 40% reduced risk of cataract and up to a 70% 
reduced risk of AMD over a follow-up period of 6-7 years in a cohort of women aged 50 to 
79 years of age. Both cataract and AMD are the leading causes of VI in older people, 
including participants of the Blue Mountains Eye Study cohort 34;159;162;204;205. 
The associations between specific nutrients and specific eye conditions have also been widely 
reported. Several studies have found conflicting evidence that the consumption of 
supplements and foods rich in Vitamin C, Vitamin E, zinc, beta-carotene may lower the risk 
of incidence and progression of cataract and AMD 206-215. Both the lens and retina are 
exposed to high levels of light, oxidative stress and metabolic activity. Lutein and xeazanthin 
are carotenoids which are highly concentrated in the macular area of the retina. Their roles 
have been suggested to be beneficial to the eye as they can filter blue light and have 
antioxidant properties and have been also been found to be associated with lower risk of 
cataract and AMD 216.  
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The long-term detrimental effects of low diet quality and unhealthy lifestyle may not 
manifest till later in life, when chronic conditions such as cardiovascular disease and diabetes 
are frequent, so that VI can be an additional burden to the quality of life of the affected 
individuals 217. The associations between diabetes and cardiovascular disease with frequent 
age-related eye diseases such as macular degeneration and cataract 218-220 may partially 
explain some of the long-term associations we found between diet quality incident VI.  
An overall diet quality score rather than a specific food or nutrient focused approach allows 
for the effects of both beneficial and detrimental foods to be considered together, including 
nutrient interactions with other nutrients, drugs and environment 221-225. A review by Lien and 
Hammond 226 highlighted the importance of these complex interactions and the vulnerability 
of the visual system. If the benefits of nutritional intervention were shown to reduce risk of 
VI and eye disease, it is plausible that by maintaining a healthier lifestyle, including 
adherence to recommended dietary guidelines earlier in life, could incur greater benefit later 
in life reducing the incidence of VI.  
Consistent with the design of the total diet score, people who had higher diet quality scores, 
consumed more vegetables (excluding potatoes), fresh fruit, wholegrain cereals, fish, lean red 
meat and low fat dairy products 198, confirming that the consumption of a variety of healthy 
foods that provide good sources of a range of nutrients, contribute to an overall healthy diet, 
consistent with dietary guidelines for Australians. The total diet score has been used 
previously to report associations between diet and reduced risk of incident kidney disease, 
pre-diabetes and all cause mortality 198;227;228. It has also been reported that a higher diet 
quality assessed with the TDS was associated with a better quality of life and functional 
ability 229. 
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Strengths of our study include its large population-based sample with reasonable follow-up 
rates and standardized methods to assess VA. We have specified incidence duration and a 
clear temporal relationship with the use of longitudinal data. Limitations include the inability 
to adjust for all confounding variables that may influence diet quality. Many factors may 
affect diet quality including age, education, stress, familial and financial status 230. Keller et al 
231 found that the most important non-biological factor to affected diet quality was income. 
Participants with healthier diets may also be more likely to be health conscious and exercise 
more regularly to benefit the heart and other organs of the body in general. The use of the 
FFQ may under- or over-estimate certain nutrient or food groups 155. Another limitation is 
survival bias; participants who were unable or refused to attend the follow-up visits, or who 
had died, could more likely have had co-morbid conditions including VI and also more likely 
to have poorer diet quality. Such bias could have reduced the magnitude of the association 
observed. Last, the total diet score or dietary behaviour could have changed over the 10-year 
period, in particular, it could have been influenced by the disease (including VI) diagnosis 232, 
we therefore decided to use only baseline TDS to avoid such indication bias.  
In conclusion, in an older population-based cohort of Australians, we documented a possible 
long-term benefit on vision from higher diet quality, indicated by adherence to published 
dietary guidelines. Further research on diet and health outcomes including vision and ocular 
diseases is merited; given that dietary consumption is the most frequent, lifetime, but 
modifiable environmental exposure that affects health directly in the longer term. 
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Section III 
Part 2: The Impact and Burdens of Visual 
Impairment 
 
Chapter 6: Visual Impairment and Subsequent use 
of Support Services among Older People 
 
 
 
 
 
 
 
 
 
 
 
 
Material in this Chapter has been published in 
Hong T, Mitchell P, Burlutsky G, Fong CS, Rochtchina E, Wang JJ. Visual impairment and subsequent use of 
support services among older people: longitudinal findings from the Blue Mountains Eye Study.  
American Journal of Ophthalmology. 2013 Aug;156(2):393-399. 
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Abstract 
Purpose: To assess the impact of visual impairment and blindness on the incident use of 
community support services in the Blue Mountains Eye Study. 
Methods: Of 3654 baseline participants (1992-94), 2334, 1952 and 1149 were re-examined 
after 5, 10 and 15 years, respectively. Incident VI was defined as subsequent development of 
VI (VA <6/12) in the better eye of subjects with best-corrected VA ≥6/12 at baseline. 
Community support service use included regular use of Meals on Wheels, Home Care or 
community nurse services. Informal support included assistance from family or friends. 
Discrete logistic regression models with time-dependent study and outcome variables were 
used to assess associations between VI and subsequent use of support, adjusted for potential 
confounders. 
Results: Among participants with bilateral VI at baseline, incident use of community 
services over 5-15 years was 41.7% compared to 19.4% in those without VI at baseline (odds 
ratio, OR, 1.39, 95% confidence interval, CI, 0.54-3.60). Participants with incident bilateral 
VI were more likely to subsequently need community support (OR 3.32, CI 1.96-5.59) in 5 
years, compared to participants without VI during the entire follow-up period. Baseline older 
age, walking disability, receiving pension and having 2+ hospital admissions within 12 
months, were also significantly associated with incident use of support services. 
Conclusions: Development of bilateral VI in this cohort was associated with greater 
likelihood of subsequent use of community or informal support services in five years, 
independent of physical co-morbidities. 
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Background 
Government-funded community support services such as the Home and Community Care 
program 233 in Australia and the Home and Community-Based Services in the United 
States234 are designed to assist older people with disabilities living at home. These programs 
support and preserve these older people’s ability to live independently, maintain their quality 
of life and minimize the number of people being admitted to long-term residential care. Some 
of the services provided under the Home and Community Care program include; Home Care 
(personal care, domestic assistance, home maintenance), nursing care, meal delivery (Meals 
on Wheels) and transport. This is becoming increasingly important given the aging 
population.  
Previously documented significant associations between the presence of visual impairment 
and the use of community support services have principally been observed in cross-sectional 
studies38;57;58. There has been no evidence from longitudinal data supporting such 
associations. In this report, we aimed to determine the impact of visual impairment (including 
its severity and duration) on the subsequent use of community support services over a period 
of 15 years in a population-based cohort of older Australians, the Blue Mountains Eye Study 
(BMES).  
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Specific Methods 
Visual impairment 
Visual impairment definitions have been described previously in chapter 2, page 67. VA 
used in this chapter refers to the best-corrected acuity after subjective refraction. 
Use of Community and Informal Support Services 
The use of community support services (formal support services) was defined as the regular 
use of one or more of the three services: Meals on Wheels, Home Care or regular home visits 
by a community nurse235. The use of informal support was defined as receiving assistance 
from either family members or friends for house cleaning or shopping. Participants using 
community support services and those using informal support were mutually excluded from 
the other category. The ability to go out alone was assessed separately. Incidence of the use 
of these support services was defined as occurring in participants who did not report using 
such services in the previous examination but did so at a later follow-up visit.  
Statistical analysis 
SAS 9.2 software (SAS Institute, Cary, NC) was used for statistical analyses. Discrete 
logistic regression models (PROC PHREG) with time-dependent study (VI) and outcome 
(formal or informal support use) variables were used to assess associations between VI and 
subsequent use of support services. Participants with incident VI detected at the 5- and 10-
year follow-up visits were assessed for subsequent uptake of support services at the next 
follow-up visit with a 5-year interval. 
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Logistic regression models (PROC LOGISTIC) were used to assess the associations between 
incident VI detected at the 5-year follow-up and subsequent uptake of support services after 
10 years (at the 15-year follow-up). All reported longitudinal associations were adjusted for 
baseline age and sex. These associations were also adjusted for the presence of a walking 
disability, home ownership, living arrangements, holding a pension, self-rated health, having 
≥2 co-morbidities (angina, acute myocardial infarct, stroke, arthritis, hypertension and/or 
diabetes) at the time when VI was detected, and having hospital admissions in the 12 month 
period prior to the visit when VI was detected. Odds ratios (OR) and 95% confidence 
intervals (CI) are presented.  
Results 
Incidence of taking up formal and informal support services in the Blue Mountains Eye 
Study cohort 
Of 3022 participants not already using formal support services at baseline the incidence of 
new community support service use over the 5-15 year period was 12.8%. Of 2239 
participants not already using informal support at baseline the incidence of new reliance on 
support from family members and friends over the 5-15 year period was 53.6%. Older 
participants were more likely to use any support service regardless of VI status. Overall, the 
incidence of reporting inability to go out alone over the 5-15 year period was 6.9%. 
Baseline visual impairment and subsequent use of support services 
Of 3654 participants at baseline, 131 (4%) were found to have bilateral VI at baseline. 
Among participants with bilateral VI who had not used support services at baseline (n=85), 
the incidence of new use of community support services over the 5-15 year period was 
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41.7%, compared to 19.4% in those without VI at baseline (adjusted OR 1.39, 95% CI 0.54-
3.60). Among participants with bilateral VI who did not rely on informal support at baseline, 
(n=59) the incidence of new use of informal support over the 5-15 year period was 61.9% in 
participants with bilateral VI compared to 31.6% in those without VI at baseline (adjusted 
OR 2.96, 95% CI 1.16-7.59). However, the new use of formal or informal support services 
was not significantly associated with unilateral visual impairment, any VI or any blindness 
(data not shown).  
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Incident visual impairment and subsequent use of support services 
Of the 3523 participants without VI at baseline, 73 developed bilateral VI and 294 developed 
unilateral VI at any follow-up visit (after 5-, 10- or 15-years). Due to the small number of 
participants with incident bilateral blindness at follow-up visits, bilateral and unilateral 
blindness were grouped together as any blindness, and occurred in 69 participants over the 
15-year period. Table 6.1 shows baseline characteristics of participants with incident 
unilateral and bilateral VI detected at any follow-up visit and participants without VI over the 
entire follow-up period. Participants with any incident VI were more likely to be older, to 
receive a pension, to live alone, have a walking disability, have 2+ chronic conditions at 
baseline, and also to have had 2+ hospital admissions in the 12 month period prior to the 
baseline examination.  
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Table 6.1: Baseline characteristics of participants without visual impairment and participants with incident unilateral and bilateral visual 
impairment at any follow-up examination among older participants in the Blue Mountains Eye Study 
Characteristic No Visual 
Impairment 
(%) N=3179 
Unilateral 
Visual 
Impairment 
(%) N=328 
Adjusted P 
value* 
Bilateral 
Visual 
Impairment 
(%) N=131 
Adjusted P 
value* 
Age at baseline (years) ± SD 64.8 ± 9.0 73.7 ±  9.4 <0.01 80.8 ±  9.1 <0.01 
Male 43.7 44.2 0.87 29.8 <0.01 
Home ownership 89.1 86.6 0.18 82.4 0.02 
Receiving pension 55.1 80.9 <0.01 89.8 <0.01 
Living alone 25.8 36.1 <0.01 47.3 <0.01 
Walking disability 5.3 15.6 <0.01 33.9 <0.01 
Chronic conditions (≥2) 16.3 25.6 <0.01 30.0 <0.01 
Hospital admissions (≥2)‡ 21.3 30.5 <0.01 38.2 <0.01 
 
* Adjusted for age, sex, home ownership, pension, living status, walking disability, chronic conditions (diabetes, hypertension, arthritis, history 
of stroke or heart disease) and hospital admissions 
‡ Within 12 months prior to baseline examination  
SD = standard deviation 
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Of 442 participants who became new (incident) regular users of community support services 
over the follow-up period, bilateral VI was present in 5.7%. Of 1303 participants who 
became newly reliant on informal support over the follow-up period, bilateral VI was present 
in 2.4%. These proportions compare to 1.3% and 1.4%, among those who did not use any 
formal or informal support, respectively.  
Of 73 participants with incident bilateral visual impairment, 46.0% became new regular users 
of community support services and 25.9% became reliant on informal support. These 
compare to 9.1% and 29.2% for formal and informal support, respectively, among subjects 
who did not have any VI over the follow-up period.  Participants with incident bilateral (OR 
3.32, 95% CI 1.96-5.59) or unilateral (OR 1.77 95% CI 1.21-2.60) VI during the follow-up 
period were subsequently more likely to become regular users of community support services 
within 5 years, compared to people without any VI over the entire follow-up period, after 
adjustment for age, sex, home ownership, and whether they lived alone, received a pension, 
had a walking disability, self-rated health, had a hospital admission in the last 12 months, or 
had 2 or more co-morbidities (diabetes, hypertension, arthritis, history of stroke or heart 
disease). However, those with incident VI were not significantly more likely to rely on family 
or friends for informal help in daily tasks within 5 years (OR 1.79 95% CI 0.70-4.55 for 
bilateral and OR 1.60 95% CI 0.92-2.80 for unilateral incident visual impairment). Incidence 
of any (bilateral or unilateral) blindness was significantly associated with an increased risk of 
subsequently taking up community support services (OR 2.68, 95% CI 1.48-4.87) and 
informal support (OR 2.46, 95% CI 0.97-6.27) within 5 years (Table 6.2). 
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Table 6.2: Associations between incident visual impairment and the incident use of support services after 5 years among older people from the 
Blue Mountains Eye Study 
Support Service 
 Community Informal Community or Informal 
 n (%) OR* 95% CI P 
value 
n (%) OR* 95% CI P 
value 
n (%) OR* 95% CI P 
value 
Visual Impairment 
Bilateral 
 
73 (46.0) 3.32 1.96-5.59 <0.01 27 (25.9) 1.79 0.70-4.55 0.22 50 (60.0) 3.10 1.67-5.78 <0.01 
Unilateral 
 
194 (25.8) 1.77 1.21-2.60 <0.01 97 (21.7) 1.60 0.92-2.80 0.10 133 (42.9) 1.92 1.30-2.83 <0.01 
Any (bilateral 
or unilateral) 
228 (32.5) 2.39 1.70-3.35 <0.01 105 (25.7) 1.78 1.07-2.97 0.03 158 (50.6) 2.35 1.64-3.37 <0.01 
Blindness 
Any (bilateral 
or unilateral) 
59 (39.0) 2.68 1.48-4.87 <0.01 23 (34.8) 2.46 0.97-6.27 0.06 41(63.4) 3.71 1.88-7.31 <0.01 
 
* Adjusted for age, sex, home ownership, pension, living status, walking disability, self-rated health, chronic conditions (diabetes, hypertension, 
arthritis, history of stroke or heart disease) and hospital admissions in the comparison of proportion of support service use between participants 
with visual impairment and those with no visual impairment.  
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However, participants with incident bilateral visual impairment, unilateral VI or blindness 
detected at the 5-year follow-up visit were not more likely to become regular users of 
community support after 10 years, at the 15-year follow-up visit (OR 0.19, 95% CI 0.03-1.30; 
OR 0.93, 95% CI 0.49-1.74 and OR 1.01, 95% CI 0.26-3.86, respectively). These participants 
were also not more likely to rely on informal support from family or friends either, after 10 
years (OR 1.64 95% CI 0.31-8.66 for incident bilateral visual impairment; OR 1.11 95% CI 
0.65-2.02 for unilateral VI and OR 2.45 95% CI 0.73-8.17 for any blindness) (Table 6.3).  
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Table 6.3: Associations between incident visual impairment and the incident use of support services after 10 years among older people from the 
Blue Mountains Eye Study 
Support Service 
 Community Informal Community or Informal 
 % OR* 95% CI P value % OR* 95% CI P value % OR* 95% CI P value 
Visual Impairment 
Bilateral (N=7) 
 
28.57 0.19 0.03-1.30 0.09 57.14 1.64 0.31-8.66 0.56 57.14 0.65 1.12-3.50 0.61 
Unilateral (N=58) 
 
31.03 0.93 0.49-1.74 0.81 39.66 1.11 0.61-2.02 0.73 50.00 1.00 0.56-1.77 0.99 
Any (bilateral or 
unilateral) (N=65) 
30.77 0.79 0.43-1.46 0.45 41.54 1.15 0.65-2.02 0.64 50.77 0.95 0.55-1.65 0.86 
Blindness 
Any (bilateral or 
unilateral) (N=13) 
38.46 1.01 0.26-3.86 0.99 61.54 2.45 0.73-8.17 0.15 69.23 1.99 0.56-7.00 0.29 
 
* Adjusted for age, sex, home ownership, pension, living status, walking disability, self-rated health, chronic conditions (diabetes, hypertension, 
arthritis, history of stroke or heart disease) and hospital admissions in the comparison of proportion of support service use between participants 
with visual impairment and those with no visual impairment. 
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Among participants with incident bilateral visual impairment, women were more likely to use 
community support services within 5 years, compared to men with the same condition (OR 
1.56, 95% CI 1.24-1.96). However, women were less likely to rely on informal support by 
family and friends compared with men (OR 0.51, 95% CI 0.42-0.63). A similar sex 
difference was evident among participants with incident unilateral visual impairment, any VI 
or any blindness (data not shown). 
Longitudinal association of visual impairment and inability to go out alone 
Incident bilateral VI was significantly associated with subsequent reduced ability to go out 
alone (OR 6.14, 95% CI 2.72-13.85) after 5 to 10 years. However, incident unilateral VI was 
not significantly associated with subsequent reduced ability to go out alone (OR 1.78 95% CI 
0.89-3.56), after adjusting for past history of angina, acute myocardial infarct, stroke, 
arthritis, hypertension and diabetes. Self-reported past histories of these systemic conditions 
at baseline, but not self-rated health, were significantly associated with subsequently 
becoming not able to go out alone (OR 2.41, 95% CI 1.62-3.58).   
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Discussion  
In our sample we found that older participants who developed incident bilateral VI and 
blindness were significantly more likely to take up community support services within the 
following 5 years than participants who remained free of VI over the entire follow-up period. 
However this association diminished by the time the 10-year follow-up visit was conducted. 
This finding could suggest that older people with bilateral VI need community support over 5 
years or so. After a period of time they may have received treatment (e.g. cataract surgery), 
adapted to the impairment, died, or moved to residential age care institutions236, resulting in a 
reduced long-term need for community support services among these people.  
Our longitudinal findings support previous cross-sectional findings from the BMES baseline 
examination235, which also reported an increased likelihood of using community support 
services (OR 3.1), reliance on family and friends (OR 2.5), and a reduced ability to go out 
alone (OR 6.2) among visually impaired participants. These findings are also consistent with 
findings from a previous hospital-based cross-sectional study by Ke et al57, which found that 
a higher proportion of participants with moderate VI compared to participants without VI 
received assistance from formal (52% vs. 35%) and informal (70% vs. 37%) support. The 
proportions of those using support services rose with increasing age and the severity of 
impairment57.  
 We found that for the same levels of visual impairment, women were more likely to rely on 
community support services and were less likely to rely on informal support than men. In our 
study, women had a greater 15-year survival than men, which could imply that some older 
women could not rely on their spouse for support, as their spouses could have already died or 
been more frail than their wife. Women have previously been found to rely more on multiple 
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sources of support compared to men237. Other cross-sectional studies238;239 found that visually 
impaired participants receiving support from both family and friends had better adaptation to 
their visual impairment, and the more social ties they had, the better their adaptation. 
Conversely to our findings, this adaptive effect appeared to be stronger among men compared 
to women 239. 
Among older populations, the proportion of participants relying on informal support was 
relatively high regardless of visual status. Our findings suggested an increased use of formal 
support only over the following few years after the onset of bilateral visual impairment.  As 
these people become older, chronic conditions and disabilities associated with aging likely 
offset the burden caused by VI and therefore over the longer term, the impact of bilateral VI 
on the use of formal support services becomes no longer apparent. It is important to note that 
these findings may only apply to developed countries, as support services may differ among 
developing countries240;241. 
Strengths of our study include its large population-based sample with reasonable follow-up 
rates and standardized methods to assess VA. We have specified a clear temporal relationship 
with the use of longitudinal data. Limitations include the inability to adjust for all potential 
confounding variables that may influence the uptake of both formal and informal support 
services such as cognitive factors. Furthermore, we did not adjust for factors which may 
improve vision such as cataract surgery or correction of refractive errors during the periods 
between follow-up visits which may have reduced the associations between VI and support 
use after 10 years. We had a relatively small number of participants with bilateral VI who 
were followed-up, which may limit our study power. Participants with bilateral VI may have 
been more likely to have been older and have more co-morbidity, and require more support 
which would have increased the association we found between VI and support use. Another 
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limitation is survival bias; participants who were unable or refused to attend the follow-up 
visits, or who had died, would likely have had more co-morbid conditions and have been 
more likely to rely on support services if they were alive, and thus selective survival would 
have reduced the study power to detect the association between VI and support use. Of 
person who had incident bilateral visual impairment, 63.9% had died by the 15-year follow-
up. We have used death as a competing event for the study outcomes of incidence use of 
formal or informal support services. Finally, the use of formal and informal support was self-
reported, which could have led to over or under-reporting of the use of these services.  
This longitudinal study complements our previous finding of a cross-sectional association 
between VI and the use of community support in a developed country, and confirms the 
impact of VI on the community aged care burden. The latest report of the World Health 
Organization242 estimates that about 285 million people have VI globally, 82% of whom are 
50 years and older. These people are approximately 3 times more likely to need some form of 
community support. These findings emphasize the burden of VI among older participants, 
and the need for regular eye health care service provision to older people. Early detection of 
VI may permit timely interventions to help older people with visual disabilities and their 
families, and to maintain their relatively independent ability to live at home as long as 
possible to reduce the aged residential care burden associated with VI37;39. 
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Section III 
Part 2: The Impact and Burdens of Visual 
Impairment 
 
Chapter 7: Long-Term Visual Impairment and the 
Incidence of Falls and Fractures among Older 
People 
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Abstract 
Purpose: To assess the impact of visual impairment (VI) on the incidence of falls and 
fractures in older persons. 
Methods: Of 3654 baseline participants, 2334, 1952 and 1149 were re-examined after 5, 10 
and 15-years. Presenting visual acuity (VA) was measured at each examination. Bilateral and 
unilateral VI was defined as VA worse than 6/12 in the better and worse eye, respectively. 
Incident VI was defined in eyes with VA 6/12 or better at baseline which subsequently 
developed VI. Incidence of falls was assessed over the 12-months prior to each visit; whereas 
incidence of fractures was assessed over the 5-years between two visits. Discrete logistic-
regression models with time-dependent variables were used to assess associations between VI 
and subsequent falls and fractures after adjusting for potential confounding variables. 
Results: The proportions of participants reporting ≥2 falls ranged between 10%-14%, and 
proportions reporting fractures ranged between12%-21%, across the three follow-up visits. 
Participants with incident VI were more likely to report ≥2 falls in 5-years, OR 1.46, 95% CI 
1.04-2.04 (bilateral) and OR 1.22, 95% CI 0.98-1.51 (unilateral). Compared to participants 
with normal vision, those with incident unilateral VI had a higher incidence of fractures over 
5-years (OR 1.27, 95%CI 0.98-1.51). No increased incidence of falls or fractures was evident 
after 5+ years among participants with VI. 
Conclusions: In this older cohort, recent development of visual impairment was associated 
with increased likelihood of subsequent falls and fractures in the next 5 years, independent of 
other confounding variables.  
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Background 
Approximately 1 in 3 persons aged 65+ years experiences a fall each year243-245, with around 
one half occurring at home and one third resulting in a fracture in the hip or thigh177;244;246. 
Known risk factors for falls and fractures include older age, female gender, past history of 
cardio-vascular disease, stroke, diabetes, arthritis, walking disabilities, depression, use of 
medications (e.g. sedatives, tranquilizers) and visual problems69;247-249.  
Previously documented significant associations between the presence of VI and an increased 
likelihood of falls and fractures were largely observed from cross-sectional studies25,26. 
Longitudinal studies with follow-up periods up to 10 years also documented an increased risk 
of subsequent falls and fractures, however the duration of VI was unclear1;12;48;111;248;250;251.  
In this report we aimed to assess the impact of bilateral and unilateral VI, and the duration a 
person lived with VI, on subsequent falls and fractures over 5- and 10-year periods in a 
population-based cohort of older Australians, the Blue Mountains Eye Study (BMES). 
Specific Methods 
Visual Impairment 
Visual impairment definitions have been described previously in chapter 2, page 67. VA 
used in this chapter refers to the presenting visual acuity before subjective refraction. 
Incidence of Falls and Fractures 
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We determined the incidence of falls over a 12-month period prior to each visit among all 
participants who were examined at the visit. The incidence of falls was categorized into 2 
groups; participants who reported 2 or more falls versus participants who reported one or no 
falls. The incidence of fractures was also categorized into 2 groups; any fractures versus no 
fracture.  
Statistical Analysis  
SAS 9.2 software (SAS Institute, Cary, NC) was used for statistical analyses. Discrete 
logistic models (PROC PHREG) with time-dependent study (VI) and outcome (any falls and 
fractures) variables were used to assess associations between VI and subsequent falls and 
fractures.  
Participants with incident VI detected at each visit were assessed for falls and fractures at 
subsequent visits with a 5-year interval. This analysis used discrete logistic regression model 
and time-dependent variables to include VI detected at 5-year follow-up and outcome events 
reported at 10-year follow-up; and VI detected at 10-year follow-up and outcome events 
reported at 15-year follow-up visits. Participants with bilateral and unilateral VI were 
compared to participants without VI in either eye over the 15-year follow-up period.  
Logistic regression models (PROC LOGISTIC) were used to assess the associations between 
incident bilateral or unilateral VI detected at the 5-year follow-up and subsequent falls and 
fractures at the 15-year follow-up visit (a 10-year interval). As falls were self-reported events, 
the exact time when each event occurred was not known, and events that occurred during the 
follow-up period but outside the 12-month period prior to the follow-up visit could have been 
omitted, we therefore used dichotomous variables (had or did not have) for both fall and 
fracture outcomes and logistic regression models to assess the longitudinal associations. 
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All models were adjusted for potential confounding variables known to be associated with 
having a fall or fracture including the presence of a walking disability, home ownership, 
living arrangements, cataract surgery within the follow-up period, having 3 or more co-
morbidities (angina, acute myocardial infarct, stroke, arthritis, hypertension and diabetes), 
use of medications which could result in falls or fractures (tranquilizer, sedatives and anti-
depressants), bifocal/multifocal spectacle correction and having any hospital admissions over 
the 12 months prior to the visit when VI was detected252. We used a p value <0.05 as the 
selection criterion for variables to be included in the final parsimonious, multi-variable 
models, unless variables needing to be adjusted for based on content knowledge. We cross-
checked all variables excluded from the final models and confirmed that each of these 
variables did not change the association between VI and the outcome variables by more than 
10% 253. Supplementary analysis using best-corrected VA measured after subjective 
refraction in place of presenting VA was also performed. Odds ratios (OR) and 95% 
confidence intervals (CI) are presented.  
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Results 
Baseline characteristics by the presence or absence of self-reported ≥2 incident falls or self-
reported fractures at any follow-up visit (5-, 10- and 15-year) are presented in Table 7.1. 
Compared to participants without subsequent events of ≥2 falls or fractures, those with ≥2 
falls were more likely to be women, to have had a hospital admission within the last 12 
months prior to baseline visit, to live alone and have a walking disability at baseline. 
Participants with subsequent factures were more likely to be women and to have had a 
hospital admission within the last 12 months prior to baseline. The proportion of participants 
reporting ≥2 falls at the 5-, 10- and 15-year follow-up examinations was 10.4%, 13.9% and 
10.4% respectively, and the corresponding proportion of participants reporting a fracture was 
20.9%, 13.2% and 11.6% respectively. 
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Table 7.1: Baseline characteristics of participants reporting falls (≥2) and fractures at any follow-up visit (5-, 10- or 15-year) 
 
 
* Adjusted for age, sex, presence of a walking disability, 3 or more co-morbidities 
Characteristic No or <2 
Falls 
n=832 
(%) 
≥ 2 Falls 
n=297 
(%) 
Adjusted 
P values* 
 No 
Fractures 
n=778 
(%) 
Fractures 
n=348 
(%) 
Adjusted 
P values* 
Age (years) ± SD 60.0 ±6.6  62.6 ± 7.3 <0.01  60.1 ± 6.8 62.1 ± 6.7 0.06 
Sex (Female) 55.1 66.7 <0.01  53.2 69.3 <0.01 
Walking disability 0.7 3.7 <0.01  1.4 1.7 0.68 
Living alone 17.6 24.8 <0.01  19.0 20.8 0.49 
Chronic conditions (3+) 3.9 6.4 0.07  4.4 4.9 0.70 
Hospital admissions (within last 12 months) 14.3 19.2 0.05  14.0 19.0 0.03 
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Baseline visual impairment and subsequent falls and fractures reported at the 5-year 
follow-up visit 
At baseline, bilateral VI was detected in 397 participants (10.9%) and unilateral VI was 
detected in 1073 participants (29.4%), of which 150 and 535 had complete data at the 5-year 
follow-up. Two or more falls in the year prior to the 5-year follow-up visit were reported by 
16.0% and 14.2% of participants with bilateral and unilateral VI at baseline, respectively, 
compared to 9.72% of those without VI in either eye at baseline; adjusted OR 1.46, 95% CI 
0.86-2.47 and 1.37, 95% CI 0.59-1.44 for participants presented with bilateral and unilateral 
VI at baseline, respectively. History of fractures in the past 5 years was reported at the 5-year 
follow-up by 26.0% and 27.1% of baseline participants with bilateral and unilateral VI, 
respectively, compared to 19.8% of participants who had no VI in either eye at baseline: 
adjusted OR 0.94, 95% CI 0.61-1.44 and OR 1.29, 95% CI 1.00-1.67 for participants with 
bilateral and unilateral VI at baseline, respectively (Table 7.2).  
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Table 7.2: Associations between baseline bilateral or unilateral visual impairment and subsequent falls (≥2) and fractures reported at the 5-year 
follow-up examination, shown as odds ratios (OR) with 95% confidence intervals (95% CI) 
 
 
 
 
 
 
 
 
 
 
 
 
* Adjusted for age, sex, presence of a walking disability, 3 or more co-morbidities 
 
  
Baseline Visual 
impairment status 
n (%) subjects 
reporting ≥2 
falls at the 5-
year follow-up 
 
OR* (95% CI) 
 
p value 
n (%) subjects 
reporting a 
fracture at the 5-
year follow-up 
 
OR* (95% CI) 
 
p value 
Bilateral (N= 150) 24 (16.0) 1.46 (0.86-2.47) 0.16 39 (26.0) 0.94 (0.61-1.44) 0.77 
Unilateral (N=535) 76 (14.2) 1.37 (0.98-1.90) 0.07 145 (27.1) 1.29 (1.00-1.67) 0.05 
Male (N=982) 89 (9.1) 1.03 (0.63-1.75) 0.12 149 (15.2) 0.51 (0.41-0.64) <0.01 
Walking disability (N=74) 24 (32.4) 0.58 (0.34-2.44) 0.45 24 (32.4) 1.29 (0.77-2.17) 0.33 
3+ Co-morbidities (N= 154) 19 (12.3) 3.32 (1.97-5.59) <0.01 34 (22.1) 0.95 (0.64-1.43) 0.81 
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Incident visual impairment and subsequent falls and fractures within 5-year intervals 
Of the 2799 participants without VI at baseline, 81 developed bilateral VI at any follow-up 
visit (5-, 10- or 15-years). Due to small numbers of incident bilateral blindness at all follow-
up visits, incidence of bilateral and unilateral blindness was grouped together as incidence of 
any blindness, and was found in 69 participants over the 15-year follow-up period.  
Participants with incident bilateral VI during the follow-up period were more likely to report 
≥2 subsequent falls in 5 years (adjusted OR 1.46, 95% CI 1.04-2.04), but were not more 
likely to report a subsequent fracture (adjusted OR 1.07, 95% CI 0.77-1.50, Table 7.3).  
 
 
Table 7.3: Associations between incident bilateral and unilateral visual impairment with 
subsequent falls and fractures in the next 5 or 10 years by duration of visual impairment, 
shown as odds ratios (OR) with 95% confidence intervals (95% CI) 
 Subsequent falls  Subsequent fractures  
Incident bilateral VI 
Duration of VI OR* (95% CI) p value OR* (95% CI) p value 
0 to 5 Years# 1.46 (1.04-2.04) 0.03 1.07 (0.77-1.50) 0.68 
>5 to 10 Years† 1.10 (0.45-2.69) 0.84 1.27 (0.53-3.06) 0.59 
Incident unilateral VI 
Duration of VI     
0 to 5 Years# 1.22 (0.98-1.51) 0.08 1.27 (1.04-1.55) 0.02 
>5 to 10 Years† 1.26 (0.79-2.01) 0.33 1.51 (0.96-2.37) 0.08 
 
*Adjusted for age, sex, presence of a walking disability, 3 or more co-morbidities 
#Proc PHREG 
†Proc LOGISTIC   
145 
 
Participants with incident unilateral VI during the follow-up period were also more likely to 
report ≥2 subsequent falls in 5 years (adjusted OR 1.22, 95% CI 0.98-1.51), although this 
association was marginally non-significant. In addition, they were significantly more likely to 
report a subsequent fracture in 5 years (adjusted OR 1.27, 95% CI 1.04-1.55).  
Supplementary analyses using best-corrected VA measured after subjective refraction in 
place of presenting VA did not significantly change the associations between incident 
bilateral and unilateral VI and subsequent report of ≥2 falls or fractures in 5 or less years 
(data not shown). 
Participants with incident blindness (unilateral or bilateral) during the follow-up period were 
not more likely to report ≥2 falls or a fracture in 5 years (adjusted OR 0.99, 95% CI 0.35-2.77 
and OR 0.71, 95% CI 0.25-1.98, respectively). 
 
Incident visual impairment and subsequent falls and fractures in more than 5 years 
Participants with incident bilateral VI detected at the 5-year follow-up visit were not more 
likely to report ≥2 subsequent falls or a fracture in 10 years, i.e. at the 15-year follow-up visit 
(OR 1.10 95% CI 0.45-2.69 and OR 1.27 95% CI 0.53-3.06 for long-term incident falls and 
fracture, respectively, Table 7.3). There were only 2 persons with incident blindness at the 5-
year follow-up (n=2), and therefore the association between incident blindness and incident 
falls or fractures over 10 years was not assessed.  
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Discussion  
We found that older persons who developed bilateral or unilateral VI during the follow-up 
period (had experienced VI recently) were more likely to report ≥2 falls within 5 years of 
visual impairment being detected, compared to participants  who remained free of VI over the 
same follow-up period. However, this association diminished after 5 or more years. While 
incident bilateral visual impairment was not associated with subsequent self-reported fracture 
at any point in time, incident unilateral VI was associated increased likelihood of subsequent 
self-reported fractures in 5-years, after adjusting for potential confounders.  
The lack of positive association between incident bilateral VI and subsequent fractures could 
have been a result of insufficient study power due to relatively small numbers.  
Our finding of longitudinal association between VI and subsequent falls complement 
previous cross-sectional findings from the baseline examination of the same population254, 
which also reported an increased likelihood of reporting ≥2 falls during the 12-month period 
prior to the study baseline (PR 1.4, 95% CI 1.1-2.0) among participants  with mild VI (VA 
6/12 to 6/18 at baseline. The non-significance of the longitudinal association between 
baseline VI and self-reported falls at the 5-year follow-up examination found in this current 
study may be due to the fact that some of these baseline participants had been living with VI 
for a long duration, as we do not have information about when VI developed prior to the 
baseline examinations for these participants.  
Similar observations were reported by other population-based, cross-sectional studies of older 
people, including the Shihpai Eye Study48 (OR 2.0, 95% CI 1.0-4.3) and the Singapore Malay 
Eye Study50 (OR 1.3, 95% CI 1.0-1.6). However, a clinic-based study by Lamoureux et al.49 
did not find significant cross-sectional associations between falls and VI, contrast sensitivity, 
stereopsis or visual field loss. A review by Ambrose et al252. on risk factors of falls among 
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older participants  reported that older participants  at high risk of falls were more frail, more 
likely to have other co-morbidities and mobility problems, all that could have reduced their 
physical activities and therefore might also reduce the chance of falls252. 
Previous longitudinal reports from the Auckland Hip Fracture Study7 showed an increased 
risk of hip fractures in 2.5 years (OR 1.3 95% CI 1.0-1.8) among persons with VA<6/9 in at 
least one eye. A study by Javitt et al 1 found that progressive vision loss in the better eye was 
associated with an increased risk of injury over a 4-year follow-up period. These previous 
findings support our observations of a short- to mid-term association between unilateral VI 
and fractures, i.e. persons with baseline and incident unilateral VI had approximately a 30% 
increased risk of fractures in subsequent 5 years but not 10 years. The significant associations 
found between unilateral but not bilateral VI and risk of fractures in this report may be due to 
the deficiency in stereo-acuity among unilateral VI cases that affects depth perception needed 
for navigating7;245. 
The Framingham Study12 reported a non-significantly increased risk of fractures over a 10-
year period retrospectively (adjusted RR 1.5, 95% CI 0.95-2.5) among persons with moderate 
VI in at least one eye (VA 6/9-6/24). In contrast, we found weakening or no associations 
between VI and falls and fractures over the long-term. There are many potential reasons that 
may explain a diminishing risk of falls and fractures associated with VI over the long-term. 
Individualized rehabilitation programs may have been implemented that addressed the 
potential risk of further falls255. Admission to aged-care facilities, when older people became 
frail and had developed other co-morbidities and disabilities, could have led to a selection 
bias in this surviving cohort sample. This may also explain our failing to detect the 
associations over the long-term.  
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Strengths of our study include its large population-based sample with reasonable follow-up 
rates and the use of standardized methods to assess VA. We have specified incidence, 
duration and a clear temporal relationship. Limitations include the inability to adjust for all 
confounding variables that may influence the risk of falls or fractures. Relatively small 
number of participants with bilateral VI at each follow-up visit may have limited the power 
of our study to detect the association between VI and the risk of falls or fractures. A major 
limitation is survival bias. Participants who did not attend follow-up visits could have been 
frailer, have had more co-morbid conditions including VI, and thus would have had more 
falls or fractures than participants who did attend, resulting in an under-reporting event rate 
of falls and fractures and potential underestimation of the associations. Additionally, falls and 
fractures were self-reported and could have been subject to recall bias256. The causes of 
fractures were not confirmed by radiology reports or hospital discharge summaries.  
Previous studies have consistently shown that visual field loss is associated with an increased 
risk of falls 257-259. Visual field, however, was not consistently measured at each follow-up 
examination in our cohort study. At baseline visit, we measured visual fields on over 80% of 
the participants. There was no single blindness case that was due to the criterion of visual 
field defect (visual field of less than 20 degrees from the point of fixation)260. 
In Australia, it was estimated that the average cost was $3906 per injury resulting from 
falls261. Over the one-year period from 2010 to 2011, the number of hospitalized injury cases 
due to falls in participants aged 65+ years was over 92,000262. Findings from previous and 
our current studies indicate that a period with a high risk of falls is within the first 5 years 
after the onset of visual impairment. Measures to minimize risk of falls should be taken soon 
after visual impairment develops255. Our findings also reinforce the need for regular eye 
examinations to detect and intervene visual impairment early among older persons, to avoid 
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adverse events such as falls and fractures and maintain their independent living status as long 
as possible.   
  
150 
 
Section III 
Part 2: The Impact and Burdens of Visual 
Impairment 
 
Chapter 8: Visual Impairment and Depressive 
Symptom among Older People 
 
 
 
 
 
 
 
 
 
 
Material in this Chapter has been published in 
Hong T, Mitchell P, Burlutsky G, Gopinath B, Liew G, Wang JJ. Visual impairment and development of 
Depressive Symptoms in among older Australian cohort: the Blue Mountains Eye Study.   
British Journal of Ophthalmology: 2015 Feb: (Epub ahead of print) 
151 
 
Abstract  
Purpose: To assess the association between visual impairment (VI) and subsequent presence 
of depressive symptoms among older persons. 
Methods: Of the 3654 baseline participants (aged 49+years) of the Blue Mountains Eye 
Study, 2334, 1952 and 1149 were re-examined after 5-, 10- and 15-years. VI was defined as 
best-corrected visual acuity <6/12 in either or both eyes. Presence of depressive symptoms 
was defined if Mental Health Index (MHI) scores were <59 or incident use of anti-depressant 
medications. Persons with VI detected at the 5- or 10-year follow-up visits were assessed for 
subsequent development of depressive symptoms in 5-years. Persons with VI detected at 
baseline or the 5-year follow-up were assessed for depressive symptoms over 10+years. 
Controls were persons without VI over the corresponding period. Discrete logistic regression 
models with time-dependent study and outcome variables were used, adjusting for potential 
confounders.  
Results: Of 1568 participants who had the MHI assessed at 2 consecutive visits, 226 had 
bilateral or unilateral VI detected 5 5ears earlier and 120 had VI 10 or more years earlier.  
Depressive symptoms were reported in 27% and 31.6% of cases with VI detected 5 and 
10+years earlier, respectively, compared to 10.8 to 11.5% of controls. There was a 
significantly greater odds of presenting depressive symptoms among VI cases detected 5-
years earlier (odds ratio, OR, 3.06, 95% confidence interval, CI 1.72-5.44), but this was non-
significant for cases detected 10+years earlier (OR 1.29, 95% CI 0.84-1.98).  
Conclusions: Visual impairment was associated with subsequently presenting depressive 
symptoms over 5 years among older persons.  
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Background 
Depression has been associated with increased the risk of suicide and mortality, as well as 
having detrimental effects on physical, mental and social functioning16;118;119. Both VI and 
depression have increasingly been recognised as major issues affecting overall well-being of 
older people113-117.  
Cross-sectional associations between VI and depression have previously been reported 
among both general populations and institutionalised residents 42;51;263, with studies showing a 
greater proportion with depression among persons with VI compared to their age-peers with 
normal vision. Few studies have reported longitudinal associations between VI and 
subsequent depressive symptoms264-266. 
In this report we aimed to assess the longitudinal association between prior diagnoses of VI 
and subsequent self-reported depressive symptoms after 5 (short-term) and 10+ years (long-
term) in a population-based cohort of older Australians, the Blue Mountains Eye Study 
(BMES).  
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Specific Methods 
Visual Impairment 
Visual impairment definitions have been described previously in chapter 2, page 67. VA 
used in this chapter refers to the best-corrected acuity after subjective refraction. Participants 
with VI detected at the previous visit 5 years earlier (e.g. from baseline to the 5-year follow-
up visit or from the 5- to 10-year follow-up visit) were included to assess short-term 
incidence of depressive symptoms. Participants with known VI detected ≥10 years earlier 
(e.g. from baseline to the 10-year follow-up visit or from the 5-year to 15-year follow-up 
visit) were included to assess long-term incidence of depressive symptoms. 
Depressive Symptoms 
We defined the presence of depressive symptoms as either self-reported mental health index 
(MHI) score <59 or incident use of anti-depressant medications by participants with no 
previous history of using such medications, at later visits after VI was detected. Participants 
with MHI <59, or who were using anti-depressant medications at the preceding visit prior to 
VI was detected, or at the same visit when VI was detect, were excluded from those at risk of 
developing depressive symptoms.  
Statistical Analysis 
SAS 9.2 software (SAS Institute, Cary, NC) was used for statistical analyses. For subsequent 
presence of depressive symptoms over the short-term, persons with any incident VI detected 
at the 5- or 10-year follow-up visits were assessed for self-reported depressive symptoms at 
the end of each 5-year interval following the detection of VI (i.e. at the 10- or 15-year follow-
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up visit). For subsequent presence of depressive symptoms over the long-term, persons with 
any prevalent VI at baseline or any incident VI detected at the 5- year follow-up visits were 
assessed for depressive symptoms at the follow-up visits with a 10-year interval (i.e. 10- or 
15-year follow-up visit). For persons with normal vision (controls), depressive symptoms 
were assessed at the corresponding time-point when the VI cases were assessed. 
Discrete logistic regression models (PROC PHREG) with time-dependent study (visual 
impairment) and outcome (self-reported depressive symptoms including incident use of anti-
depressive medications) variables were used to assess associations between visual 
impairment and subsequently self-reported depressive symptoms. 
All reported longitudinal associations were after adjusted for covariates known to be 
associated with depression116;267;268 including; age, sex, presence of walking disability, living 
arrangements, having ≥3 co-morbidities (angina, acute myocardial infarct, stroke, arthritis, 
hypertension and diabetes) measured at the time when visual impairment was detected, and 
having hospital admissions in the 12-month period prior to the visit when visual impairment 
was detected. Odds ratios (OR) and 95% confidence intervals (CI) are presented.  
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Results 
Of the 3654 baseline participants, 1568 had completed the MHI questionnaires on at least 2 
consecutive visits and were included to assess the presence of depressive symptoms. Table 
8.1 shows baseline characteristics of persons with incident depressive symptoms versus those 
without depressive symptoms at the 5-year follow-up examination. Compared to participants 
without self-reported depressive symptoms, those with depressive symptoms were more 
likely to be women, to have walking disability or arthritis and were less likely to own their 
home. 
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Table 8.1: Baseline characteristics of Blue Mountains Eye Study participants by the presence 
of depressive symptoms at the 5-year follow-up examination 
 
  
* Defined as mental health index of <59 or the use of antidepressants 
Baseline characteristics 5-year follow-up 
With depressive 
symptoms* 
n (%) 
5-year follow-up 
Without 
depressive 
symptoms 
n (%) 
P Value 
Age (years) mean ± standard 
deviation 
64.4 ± 8.9 64.4 ± 8.5 0.95 
Gender (Female) 205 (65.7) 1038 (56.7) <0.01 
Any Visual Impairment (VA <6/12) 17 (5.5) 140 (7.7) 0.17 
Any Blindness (VA<6/60) 5 (1.6) 31 (1.7) 0.91 
Lives alone 86 (27.8) 454 (25.1) 0.30 
Walking disability 18 (5.8) 48 (2.6) <0.01 
Married 195 (62.7) 1223 (66.9) 0.14 
Home owner 270 (88.8) 1660 (92.5) 0.03 
History of     
       Stroke 15 (4.8) 57 (3.1) 0.31 
       Diabetes 23 (7.4) 116 (6.3) 0.49 
       Arthritis 182 (58.7) 827 (45.4) <0.01 
       Hypertension 234 (75.2) 1271 (69.6) 0.04 
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Incident bilateral or unilateral VI was recorded in 226 participants at either the 5- or 10-year 
follow-up visit, of which 27.0% (n=61) had subsequently reported depressive symptoms over 
the short-term, compared to 11.5% (n=66) of persons without VI over the same 5-year period. 
There were 120 participants with VI at either the baseline or 5-year follow-up visit, of which 
31.7% (n=38) had subsequently reported depressive symptoms at either the 10- or 15-year 
follow-up visit, compared to 10.8% (n=133) of those without VI over the same period.  
Participants with incident VI detected 5 years earlier were significantly more likely to report 
depressive symptoms at their first subsequent visit after VI detection, compared to those 
without VI (adjusted OR 3.06, 95% CI 1.72-5.44). Conversely, participants with VI detected 
10+ years earlier were non-significantly more likely to report depressive symptoms compared 
to persons without VI over the same period (OR 1.29, 95% CI 0.84-1.98, Table 8.2). 
Of the 226 participants who had incident VI diagnosed at the 5-year or 10-year follow-up 
visit, 22 had persistent VI over the entire 5-year follow-up duration. Analysis confined only 
to those with persistent VI showed a similar direction of association, but the association 
became non-significant (OR 1.57, 95% CI 0.88-2.81).  
The greater odds over the short-term of reporting depressive symptoms among participants 
with VI detected 5 years earlier was similar between those with incident bilateral VI (OR 
4.60, 95% CI 1.67-12.69) and those with incident unilateral VI (OR 4.06, 95% CI 2.06-7.99). 
The non-significant increased odds over the long-term for reporting depressive symptoms in 
participants with VI detected 10+ years earlier was also similar between unilateral and ‘any 
VI’ cases (Table 8.2). 
When we stratified depressive symptoms into two separate outcomes (MHI <59, and the 
incident use of anti-depressant medication), we found similar associations. There was 
significantly increased short-term, but non-significantly increased long-term likelihood of 
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having either outcomes among cases with any VI or unilateral VI. There was no increased 
risk of having either of the two outcomes, or the combined outcome, among persons with 
bilateral VI detected 10+ years earlier (Table 8.2).  
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Table 8.2: Longitudinal association between visual impairment and subsequent presence of depressive symptoms assessed by the mental health 
index (MHI) and the incident use of anti-depressive medication, presented as odds ratio (OR) and 95% confidence interval (CI) 
  
n 
Subsequent presence of  
Depressive symptoms  
(MHI <60) 
Incidence of 
Anti-depressive medication 
use 
Subsequent presence of   
Depressive symptoms 
(MHI<59 or the incident use of 
anti-depressants) 
Period when Visual impairment was 
detected 
 OR* 95% CI OR* 95% CI OR* 95% CI 
Bilateral         
5 years earlier 73 2.81 0.85-9.32 1.37 0.68-2.78 4.60 1.67-12.69 
10+ years earlier 15 0.72 0.15-3.39 0.72 0.15-3.37 0.63 0.17-2.34 
Unilateral         
5 years earlier 153 2.56 1.31-5.02 1.84 1.13-3.02 4.06 2.06-7.99 
10+ years earlier 105 1.36 0.80-2.31 1.25 0.74-2.12 1.47 0.90-2.20 
Any (Bilateral or Unilateral)        
5 years earlier 226 2.31 1.20-4.44 1.88 1.17-3.03 3.06 1.72-5.44 
10+ years earlier 120 1.27 0.76-2.12 1.18 0.71-1.97 1.29 0.84-1.98 
 
* Adjusted for age, sex, walking disability, hospital admissions in the past 12 months, living arrangements, having 3+ co-morbidities (arthritis, diabetes, stroke and 
cardiovascular disease, hypertension). 
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Discussion 
In this population, we found that older participants with any or unilateral VI were more likely 
to subsequently report having depressive symptoms in the short-term (5 years), but not in the 
long-term (10+ years), compared to participants without VI. These longitudinal findings 
support earlier cross-sectional data.  
A meta-analysis of 12 studies by Huang et al41, reported a higher prevalence of depression 
among persons with low vision compared to those with normal vision (pooled OR 1.94, 95% 
CI 1.68-2.25). A study by Evans et al42, found that older persons (75+ years) with bilateral VI 
had a higher prevalence of depression (OR 2.69, 95% CI 2.03-3.56, adjusted for age and 
gender). However, this association did not persist after further adjustment for other potential 
confounders including activities of daily living (ADL) (OR 1.26, 95% CI 0.94-1.70), possibly 
partly due to over-adjustment in addition to removal of confounding effects. 
Noran et al269 found that depression was more frequent in persons with bilateral VI (VA 
<20/60) and blindness (VA <20/400) (adjusted OR 2.64, 95% CI 1.27-5.5 and OR 4.99, 95% 
CI 1.90-12.95, respectively) among 430 elderly Malays (60+ years). They also assessed the 
associations between depression and the reported duration of VI, and found that depression 
was more frequent found among persons with VI for less than one month compared to those 
without VI (unadjusted OR 21.8, 95% CI 10.35-45.90).  
Longitudinal studies assessing the association between VI and depression have reported 
conflicting results. Tournier et al5 found that VI was independently associated with a greater 
incidence of depression among an older population (65+ years) after adjusting for potential 
confounding factors, and that the association was similar across different severity levels of 
VI, hazard ratio (HR) 1.54, 95% CI 1.40-1.69 for moderate and HR 1.56, 95% CI 1.43-1.71 
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for severe VI. A study by Harris et al2  reported that persons with poor vision over a 2-year 
period were more likely to develop new onset of depression (adjusted OR 2.9, 95% CI 1.3-
6.3). In addition, worsening vision between baseline and the 2–year follow-up visit was 
associated with new onset of depression (adjusted OR 3.4, 95% CI 1.6-7.1). In contrast, a 
study by Prince et al8 examined 889 residents (65+ years) over a 1-year period and reported 
that self-reported eyesight problems were not associated with development of depression over 
1 year (adjusted OR 0.8, 95% CI 0.3-2.1). A study by Forsell et al4 did not find an association 
between VI and the onset of depression after 3 years in a Swedish population aged 75+ years. 
None of these reports has provided any definitions for poor or worsening vision, eyesight 
problems or VI, to enable useful comparison between studies.  
Nevertheless, our study findings support the associations between VI and the subsequently 
self-reported depressive symptoms over the short-term (≤ 5 years). The weaker association 
between VI and self-reported depressive symptoms over the long-term may be partly 
explained by reduced numbers and therefore reduced study power, and/ or a progressive 
adaptation to VI. Factors such as support from family, friends, formal support services and 
the use of visual aids may play also role270;271. 
Strengths of our study include its large population-based sample with reasonable follow-up 
and standardised methods to assess VA. We have specified a clear temporal relationship with 
the use of longitudinal data. Limitations include the inability to adjust for all potential 
confounding variables that could have influenced the risk of developing depressive 
symptoms. We did not adjust for factors which may improve vision such as cataract surgery 
or refractive correction which may have reduced the associations between VI and depressive 
symptoms. The multi-factorial nature of depression could have been due to many other 
conditions that we could not adequately adjust for, such as cerebrovascular disease, hearing 
loss, low economic status, neurological abnormalities, cataract surgery, a past history of or a 
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family history of depressive symptoms8. We had a relatively small number of participants 
with VI and depressive symptoms who were followed-up over 10+ years, limiting our study 
power in the assessment of subsequently self-reported depressive symptoms over the long-
term. Another limitation is survival bias of the cohort, such that persons who were unable or 
refused to attend the follow-up visits, or who had died, could have had more co-morbid 
conditions including depression while alive. 
In summary, findings from this older cohort support previous cross-sectional associations 
found between VI and depression over the short-term. Persons with VI were 3-fold more 
likely to report depressive symptoms within a 5-year period after the development of VI. The 
magnitude of this association declined over the period of 10+ years. Our findings emphasise 
the importance of early detection of visual problems and rehabilitation to reduce the burden 
and negative impact of visual impairment in older people.  
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Abstract 
Purpose: To assess the associations of visual impairment (VI) and hearing loss (HL) with a 
decline in mini-mental state examination (MMSE) scores over time in older people. 
Methods: Of the 3654 participants of the Blue Mountains Eye Study baseline examination, 
2334, 1952 and 1149 were re-examined after 5-, 10- and 15-years. MMSE was assessed at all 
three follow-up visits. A decline ≥3 scores from 5-year to 10- or 15-year visits indicated 
probable cognitive decline. VI was defined as best-corrected visual acuity <6/12 in the worse-
eye, HL was defined as pure-tone average >40 decibels in the worse-ear and dual sensory 
impairment (DSI) was defined by the co- presence of VI and HL, detected at 5-year follow-
up (baseline of this report). Participants with no VI and HL over the corresponding period 
were controls. Associations of VI, HL and DSI with probable cognitive decline were assessed 
using logistic regression models adjusting for age and sex after excluding subjects with a 
stroke history. 
Results: The presence of VI, HL or DSI was not associated with probable cognitive decline 
over 5 years (odds ratio (OR) 0.84, 95% confidence-intervals (CI) 0.40-1.79, OR 1.02, 95% 
CI 0.61-1.70 and 1.41, 95% CI 0.54-3.72, respectively) or 10 years (OR 1.09, 95% CI 0.52-
2.30, OR 1.09, 95% CI 0.65-1.82 and 1.15, 95% CI 0.28-4.73, respectively). There were no 
changes to these findings after adjustment for other potential confounders. Age was 
significantly associated with probable cognitive decline (OR 1.07, 95% CI 1.04-1.10 for both 
periods). 
Conclusion: Neither visual impairment, hearing loss or dual sensory impairment were 
independently associated with subsequent decline in cognition. 
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Background 
Several cross-sectional studies previously reported associations between sensory impairments 
and cognitive decline43;44;46, including a report using Blue Mountains Eye Study (BMES) 
baseline data45 that showed a weak but significant cross-sectional association between 
sensory and cognitive function. However, findings of these associations using samples drawn 
from community dwelling or institutionalized older residents have been inconsistent after 
adjusting for potential confounding factors43-46. 
Only a limited number of longitudinal studies have assessed the associations between sensory 
and cognitive function decline in older persons, and conflicting findings have been reported 
from the few studies conducted9;11;13. Limitations of previous studies include unclear 
definitions of sensory impairment (the loss of visual or hearing impairment), use of non-
standardized methods to assess visual and hearing function, and cognitive function 
assessment tools have included vision-related testing items. 
In this report we aimed to determine whether longitudinal associations existed between 
visual, hearing and dual sensory impairment and probable cognitive decline over 5 and 10 
years in a population-based cohort of older Australians, using the mini-mental state 
examination (MMSE) instrument, after removing visually dependent tasks (termed MMSE 
blind).  
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Specific Methods 
Visual Impairment 
Visual impairment definitions have been described previously in chapter 3, page 53. 
However, VA used in this chapter refers to the best-corrected acuity after subjective 
refraction. 
Hearing Impairment 
Hearing loss (HL) was defined as the pure-tone average of the audiometric hearing thresholds 
at 0.5, 1, 2 and 4 kilohertz (kHz) (PTA0.5-4 kHz) >40 decibels (dB)9;272.  
Dual Sensory Impairment 
Dual sensory impairment (DSI) was defined at the co-presence of both VI and HL according 
to the definitions above.  
Cognitive Function 
We define a decline of ≥3 MMSE blind scores between the 5-year and 10- or 15-year follow-
up visits to be indicative of probable decline in cognitive function, over either 5 years 
(between the 5- and 10-year) or 10 years (between the 5- and 15-year).  
Statistical analysis  
SAS 9.2 software (SAS Institute, Cary, NC) was used for statistical analyses. Logistic 
regression models (PROC LOGISTIC) were used to assess the associations between VI, HL 
and DSI with probable cognitive decline over 5 and 10 years. All measures, VI, HL and 
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MMSE were assessed at the 5-year and later follow-up examinations. VI and HL assessed at 
the 5-year follow-up examinations were used as the study factors, and MMSE assessed 
subsequently over the follow-up period were used to assess the decline in MMSE over time 
(outcome factor). In the primary analyses, VI was defined as VA<6/12 in the worse eye, and 
HL as average PTA0.5-4 kHz >40dB in the worse ear, to include unilateral and bilateral 
impairment cases. In supplementary analyses, VI was defined as VA<6/12 in the better eye, 
and HL as average PTA0.5-4 kHz >40dB in the better ear, to include bilateral impairment cases 
only. 
All reported longitudinal associations were after adjusting for baseline age and sex initially. 
Further adjustments for factors known to be associated with cognitive impairment61;273, 
including the presence of  walking disability, living arrangements (whether or not they live 
alone), home ownership, the highest educational qualification obtained, baseline MMSE 
score,, having ≥3 major co-morbidities (angina, acute myocardial infarct, arthritis, 
hypertension and diabetes), history of depressive symptoms and having hospital admissions 
in the 12 month period prior to baseline. A history of stroke is known to be associated with a 
reduced cognitive function161;274;275, hence persons with a past history of stroke were 
excluded (n=98). Odds ratios (OR) and 95% confidence intervals (CI) are presented.  
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Results 
Of the 3654 baseline participants of the BMES, 2334 were re-examined at the 5-year follow-
up visit. Of these 2334, 1605 (68.8%) had completed the MMSE in at least 2 follow-up 
examinations and therefore were included in this report.  Compared to participants who 
attended the 5-year follow-up, participants who were alive but did not attend the follow-up 
examinations were more likely to be current smokers, have a history of diabetes, late age-
related macular degeneration and VI. Participants who had died by the 5-year follow-up were 
more likely to have more chronic co-morbidities201. Table 9.1 shows the baseline 
characteristics of those with VI, HL and DSI measured at the 5-year follow-up examination. 
Compared to participants with no sensory impairments, participants with DSI were more 
likely to be older, to live alone, to have a walking disability, self-reported history of 
depressive symptoms, 3+ major co-morbidities, hospital admissions 12 months prior to 
baseline, and a lower mean MMSE blind score. 
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Table 9.1: Characteristics of Blue Mountains Eye Study participants with visual impairment, hearing loss and dual sensory impairment 
compared to participants with no sensory impairment measured at the 5-year follow-up examination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MMSE – mini-mental state examination
* Visual impairment defined as (Visual acuity <6/12) in the worse eye 
† Hearing loss defined as (>40 dB) in the worse ear 
‡ mean (standard deviation) 
Baseline characteristics No Sensory 
impairment 
n (%) 
Visual 
impairment* 
n (%) 
Hearing 
Impairment†  
n (%) 
Dual Sensory 
impairment 
n (%) 
N 1308 152 330 93 
MMSE blind score‡ 21.1 (1.5) 20.6 (2.1) 20.3 (2.3) 19.3 (2.8) 
Age (years)‡ 66.9 (7.4) 74.3 (8.4) 73.4 (7.8) 80.4 (7.0) 
Gender (Female) 544 (41.6) 52 (34.2) 171 (51.8) 40 (43.0) 
Lives alone 303 (23.2) 60 (39.5) 94 (28.5) 42 (45.2) 
Walking disability 62 (4.7) 24 (14.6) 48 (14.6) 34 (36.6) 
Home owner 1228 (94.0) 136 (89.5) 303 (91.8) 83 (89.3) 
Hospital admissions 12 months prior 306 (23.5) 43 (28.5) 78 (23.8) 33 (35.9) 
History of depressive symptoms 129 (10.7) 15 (11.5) 40 (13.1) 13 (18.1) 
3+ major co-morbidities 140 (10.7) 33 (21.7) 53 (16.2) 19 (20.9) 
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Among 1352 participants who had MMSE assessed at both the 5- and 10-year follow-up 
examinations, probable cognitive decline was found in 9.5%, 11.1% and 18.8% of 
participants with VI, HL and DSI respectively, compared to 7.6% of controls over a 5-year 
period. Of 860 participants, who had MMSE assessed at both the 5- and 15-year follow-up 
examinations, probable cognitive decline was found in 21.9%, 20.8% and 30.0% of 
participants with VI, HL and DSI, respectively, compared to 16.0% of controls over a 10-year 
period. 
Compared to participants with no sensory impairment, participants with VI, HL or DSI were 
not significantly associated with probable cognitive decline over 5 years (OR 0.84, 95% CI 
0.40-1.79, OR 1.02, 95% CI 0.61-1.70 and 1.41, 95% CI 0.54-3.72, respectively) after 
adjusting for age and sex (Table 9.2). Similarly, participants with VI, HL or DSI were not 
significantly associated with probable cognitive decline over 10 years (OR 1.09, 95% CI 
0.52-2.30, OR 1.09, 95% CI 0.65-1.82 and 1.15, 95% CI 0.28-4.73 respectively) (Table 9.3). 
Older age was found to be significantly associated with probable cognitive decline over both 
periods of 5 and 10 years, with an identical magnitude of association (per year increase in 
age, OR 1.07, 95% CI 1.04-1.10). 
  
171 
 
Table 9.2: Age- and sex-adjusted associations between sensory impairment and probable 
cognitive decline (≥3 units) in mini-mental state exam (MMSE) blind scores over 5 years 
(BMES II to BMES III) 
 
 
 
 
 
 
 
 
 
 
Table 9.3: Age- and sex-adjusted associations between sensory impairment and probable 
cognitive decline (≥3 units) in mini-mental state exam (MMSE) blind scores over 10 years 
(BMES II to BMES IV) 
 
 
 
 
 
 
  
 Decline ≥3 MMSE blind scores 
Sensory impairment n (%) OR 95% CI 
Visual impairment 
Hearing loss 
Dual sensory impairment 
9 (9.5) 0.84 0.40-1.79 
24 (11.1) 1.02 0.61-1.70 
6 (18.8) 1.41 0.54-3.72 
 Decline ≥3 MMSE blind scores 
Sensory impairment n (%) OR 95% CI 
Visual impairment 
Hearing loss 
Dual sensory impairment 
25 (21.9) 1.09 0.52-2.30 
10 (20.8) 1.09 0.65-1.82 
3 (30.0) 1.15 0.28-4.73 
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There were no significant changes in these associations between VI, HL or DSI and probable 
cognitive decline after further adjusting for other co-variables: walking disability, living 
arrangements, home ownership, the highest educational qualification obtained, baseline 
MMSE score, a history of depressive symptoms, hospital admissions in the past 12 months 
and having 3 or more major chronic co-morbidities (data not shown). Supplementary analysis 
using VI in the better eye and HL in the better ear showed no significant associations with 
probable cognitive decline over either 5-years (OR 1.19, 95% CI 0.64-2.20 for bilateral VI 
and OR 1.04, 95% CI 0.22-4.93 for bilateral HL, respectively) or 10-years (OR 1.35, 95% CI 
0.72-2.53 for bilateral VI and OR 2.08, 95% CI 0.46-9.43 for bilateral HL, respectively). 
Bilateral DSI, defined using VI in the better eye and HL in the better ear, showed similarly no 
significant associations with probable cognitive decline over 5 years (OR 6.48, 95% CI 0.37-
113.0). We could not assess the association between DSI and probable cognitive decline over 
10 years due to small numbers.  
Discussion 
In this older Australian cohort, we found that higher proportions of participants with visual, 
hearing or dual sensory impairment had a decline in 3+ MMSE blind scores after 5 and 10 
years compared to participants with no sensory impairment. However, we did not find a 
significantly increased risk of probable cognitive decline after adjusting for age and sex, or 
after further adjusting for more potential confounding variables.  Older age was significantly 
associated with a greater risk of cognitive decline. 
Very few numbers of longitudinal studies on the associations between sensory impairment 
and cognitive function have been reported9;11. The Study of Osteoporotic Fractures (SOF)9 
examined 6112 women age 69+ years and reported a cognitive decline by ≥3 units 
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approximately after an average of 4.4 years, using a modified MMSE. Using comparable 
definitions of sensory impairments to our study, SOF study investigators found that VI and 
combined vision and hearing impairment at baseline was associated with probable cognitive 
decline (OR 1.78 95% CI 1.21-2.61 and OR 2.19 95% CI 1.26-3.81, respectively), after 
adjusting for education, smoking, vertebral fracture, body mass index (BMI), grip strength, 
social network and baseline cognitive status9. However, the modified version of the MMSE 
(3MS) used in the study did not exclude vision-related.  
The Maastricht Aging Study 11 examined 418 participants aged 55+ years and found that a 
deterioration of VA was in parallel with deterioration in cognitive function over a 6-year 
period. Various cognitive performance tests were used in this study, though some tests were 
vision-related, the study investigators reported that the font size was large enough for all 
participants to perceive the words well. They found a parallel decline in both sensory and 
cognitive functions could suggest overall neurodegenerative changes associated with ageing.   
The Hispanic Established Populations for Epidemiologic Studies of the Elderly13 examined 
2140 Mexican Americans aged 65+ years, and found that participants with near VI (<7-point 
type size) at baseline had an average decline of 0.13 more MMSE-blind points per year than 
the decline in persons with normal near vision over the 7 year period (p=0.045). They found 
no difference in per year change of MMSE-blind scores between persons with binocular 
distance VI and those with normal distant vision at baseline (p=0.14)13. Vision assessment 
methods used in this study were not standardised, nevertheless, the latter finding from this 
study is consistent with our findings. 
Longitudinal studies on the associations between hearing loss and cognitive function have 
also been inconsistent. Both the Health, Aging and Body Composition study276 (3075 
participants aged 70-79 years), and the Maastricht Aging Study11(418 participants aged 55+ 
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years) found that baseline hearing impairment was associated with a decline in cognitive 
function after 5 and 6 years respectively. However, a study by Glennis et al277 did not find 
any significant associations between hearing impairment and subsequent cognitive function 
after 5 years among 122 participants aged 60+ years. Different methods of cognitive function 
testing were used across the 3 studies, which makes comparison with our findings difficult. 
Our negative findings on the associations of interest may suggest that previously reported 
positive associations between sensory function impairment and decreased cognitive function 
testing scores are unlikely due to true cognitive impairment but more likely due to the 
reduced ability to process stimuli in persons with sensory impairment that compromised the 
performance on cognitive function testing11;278. 
Strengths of our study include its large population-based sample with reasonable follow-up 
rates and standardized methods to assess vision and hearing. Limitations include the 
relatively small number of participants with visual or hearing impairment who were followed 
limiting the study power. We did not adjust for all potential variables which may have 
affected the associations between sensory impairment and cognitive decline. The MMSE is a 
screening tool, which should not be considered equivalent to specific diagnostic tools for 
cognitive impairment and a decline of 3 MMSE score may not be a valid representation of 
cognitive decline despite this level of change being used in previous studies9. Furthermore, 
reading letters off a vision chart may not be sufficiently cognitively challenging to detect any 
association between VI and subsequent cognitive decline. We could not adjust for other 
potential confounders. Although we adjusted for 3 or more major chronic co-morbidities as a 
potential confounding variable, each individual co-morbid condition may not have equal 
magnitude of association with cognitive decline. Furthermore, improvement in vision or 
hearing may have occurred subsequent to cataract surgery or the use of hearing aids during 
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the course of the follow-up period which may have contributed to the lack of association 
between sensory impairment and cognitive decline. Another limitation is survival bias: 
participants who were unable or refused to attend the follow-up visits, or who had died, 
would be more likely to have been older and have had more co-morbid conditions including 
sensory impairment, and may have been more likely to experience cognitive decline. 
In summary, we did not find significant associations between sensory impairment and 
subsequent decline in MMSE scores after adjusting for age and sex or after additional 
adjustments for multiple potential confounders. We found, however, non-significantly higher 
proportions of participants with single or dual sensory impairment who had cognitive decline 
over time, which may warrant earlier detection and intervention. Longitudinal studies with 
larger sample sizes, clearly defined sensory impairment duration, and the use of appropriate 
testing tools to disentangle cognitive impairment from sensory impairments, are needed to 
confirm or refute the hypothesis that sensory impairment may lead to an increased risk of 
cognitive decline among older persons. 
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 Section IV 
Implications of the Study Findings 
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Section IV 
 
Chapter 10: Implications of the Study Findings  
 
This thesis has addressed a number of important issues relating to the long-term changes in 
visual acuity, the incidence of visual impairment and blindness, and the short- and long-term 
impacts of visual impairment among older Australians.  
Together with other population-based longitudinal studies such as the Beaver Dam Eye 
Study14, longitudinal data from the Blue Mountains Eye Study cohort provide an 
understanding of changes in visual acuity, and the changes over time in the impact of visual 
impairment on affected individuals, families and communities. 
This thesis found a large proportion (approximately 40%) of people diagnosed with mild 
visual impairment were estimated to improve to normal vision over the course of 15 years. 
while only approximately 10% of older participants with moderate/severe visual impairment 
were estimated to improve to no visual impairment over the same follow-up period. The 
dynamic changes seen in vision over time accentuate how aging is not necessarily a 
downward slope, but a journey of ups and downs. These findings highlight the importance of 
early detection and treatment of visual impairment, and also the potential effectiveness of 
intervention and eye care services provided to older Australians. 
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This thesis explored the relationships between changes in visual acuity and the subsequent 
impact of visual impairment on affected individuals, families and the community over the 
short- and long-terms. Compared to older participants with normal vision, a greater short-
term impact of visual impairment was observed on the following health outcomes, measured 
5 years after visual impairment was detected: risk of having falls or fractures, self-reported 
depressive symptoms and the use of support services. However, these impacts were not 
sustained over the longer-term in 10 or more years. These findings suggest that early 
rehabilitation and support services provided shortly after visual impairment develops may 
maximize the benefit to the affected individuals and minimize the long-term burden to their 
families and communities. The lack of long-term associations found between visual 
impairment and risk of having falls or fractures, self-reported depressive symptoms and the 
use of support services may have also been due to an improvement of vision following 
treatment of visual impairment such as cataract surgery. As was estimated in Chapter 4, 
visual impairment can either worsen or improve over time.  Furthermore, participants may or 
may not be classed as visually impaired depending on the definitions of visual impairment 
(bilateral or unilateral) used in the analysis. The fluctuation in vision and various definitions 
of visual impairment used incurs limitations when analysing long-term data. Further 
investigation in studies with much larger samples is warrant to allow for dynamic changes of 
vision (improvement or worsening) over time.”  
This thesis also explored the associations between sensory impairment and subsequent 
decline in cognitive function over 10 years. We did not find any increased risk of cognitive 
decline among older participants with visual, hearing, or dual sensory impairment in the 
subsequent 5 or 10 years, using a modified screening tool without vision function-dependent 
tests. This finding is consistent which some, but not all, previous reports11;13. Conflicting 
findings in this regard9 may be due to the use of different cognitive function assessment tools, 
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and quite often visual function-dependent tasks were not excluded in previous studies. 
Further studies with large sample size, long-term follow-up durations and the use of more 
comprehensive and specific assessment tools are needed to confirm our findings.  
This thesis also identifies a potential long term benefit of a healthy diet and lifestyle in 
prevention of visual impairment among older participants. Findings from this thesis may 
assist improving eye health services, planning and developing visual impairment prevention 
and rehabilitation programs for the older population sector. These findings also support the 
concept of precision medicine via tailoring the healthcare need for individual patients to 
optimise the cost-effectiveness of health and aged care services. With the ongoing 
development of more effective treatment strategies for causes of visual impairment such as 
anti-vascular endothelial growth factor (anti-VEGF) for age-related macular degeneration and 
less invasive cataract surgery, we may see a reduction in visual impairment rates in the 
future. 
Like many developed countries, the Australian population is aging rapidly. In 2012, 
approximately 14% of the population were aged 65 years or older170. The anticipated increase 
in cost of, and the demand for, health and aged care will soon be beyond the capacity that the 
Medicare system can sustain. Prevention and early detection of visual impairment should be 
implemented into primary health care provision, and if detected, early treatment of 
amendable causes of visual impairment by eye health care professionals follows. 
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